Notices of Compliance, 2022
2,450 notices issued in 2022, newest first.
| Date | Products | Company | Submission |
|---|---|---|---|
| December 30, 2022 | PMS-CETIRIZINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 30, 2022 | PHENYTOIN SODIUM | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 30, 2022 | TEVA-FULVESTRANT INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 30, 2022 | NAT-TERIFLUNOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 30, 2022 | TEVA-TRAMADOL/ACETAMINOPHEN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 29, 2022 | ACARIZAX | Alk-Abello Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | FRAGMIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | NUWIQ | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | FABRAZYME | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | AG-MONTELUKAST | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 29, 2022 | CETIRIZINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 29, 2022 | ATIVAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | JANUVIA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | TARO-SIMVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 29, 2022 | SANDOZ OMEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 29, 2022 | PMS-OLANZAPINE; PMS-OLANZAPINE ODT | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 29, 2022 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 29, 2022 | JAMP GATIFLOXACIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 28, 2022 | SOLIFENACIN SUCCINATE TABLETS | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2022 | ZOPICLONE TABLETS | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 28, 2022 | NRA-ZOPICLONE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 28, 2022 | NAT-IMATINIB | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2022 | JAMP-CHOLESTYRAMINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 28, 2022 | PHARMA-LACOSAMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 28, 2022 | APO-ZIDOVUDINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 28, 2022 | JAMP ALLOPURINOL TABLETS | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 28, 2022 | NEXGARD COMBO | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | OMVYENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 23, 2022 | AZARGA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | HEMLIBRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | VENLAFAXINE XR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 23, 2022 | MAR-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 23, 2022 | APO-ESOMEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 23, 2022 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 23, 2022 | SANDOZ AMOXI-CLAV TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 23, 2022 | SIMBRINZA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | ADACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | TIAZAC | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | PROGRAF | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | JCOVDEN | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 23, 2022 | AZACITIDINE FOR INJECTION | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 23, 2022 | PEMETREXED DISODIUM FOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| December 22, 2022 | ISOVUE MULTIPACK-300; ISOVUE MULTIPACK-370 | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2022 | AURO-LACOSAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2022 | ASA EC | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 22, 2022 | MINT-PAROXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2022 | MIDAZOLAM INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2022 | IPG-TOPIRAMATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2022 | ACH-TACROLIMUS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2022 | CHOLESTYRAMINE-ODAN | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 22, 2022 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2022 | DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 22, 2022 | QULIPTA | AbbVie Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 22, 2022 | CANAURAL | Dechra Veterinary Products Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2022 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2022 | RISPERIDONE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| December 21, 2022 | DORZOLAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 21, 2022 | MINT-RASAGILINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 21, 2022 | M-VENLAFAXINE XR | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 21, 2022 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 21, 2022 | NAPROXEN SODIUM; NAPROXEN SODIUM DS | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 20, 2022 | REDDY-CLOBETASOL SHAMPOO | Dr. Reddy's Laboratories Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2022 | CAVERJECT STERILE POWDER | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2022 | NAPROXEN; NAPROXEN EC | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 20, 2022 | BETASERON | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2022 | M-CLARITHROMYCIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 20, 2022 | PEDIAPHARM NAPROXEN SUSPENSION | Medexus Inc | New Drug Submission (NDS) · Admin |
| December 20, 2022 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 20, 2022 | SUCROMATE EQUINE | Dechra Regulatory Bv | New Drug Submission (NDS) · Admin |
| December 20, 2022 | AURIMIC | Richter Pharma Ag | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2022 | GPC-METFORMIN XR | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2022 | CARBOPLATIN INJECTION BP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2022 | KYMRIAH | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| December 19, 2022 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2022 | APO-HYDROXYQUINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2022 | PMS-PAROXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2022 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2022 | IMODIUM CALMING LIQUID; IMODIUM LIQUI-GELS; IMODIUM QUICK DISSOLVE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2022 | ATORVASTATIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 19, 2022 | NUCEIVA | Evolus Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| December 19, 2022 | BORTEZOMIB FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 19, 2022 | APO-METHADONE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 19, 2022 | IBUPROFEN CAPLETS 200 MG; IBUPROFEN TABLETS 200 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 16, 2022 | MIFEGYMISO | Linepharma International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2022 | JAMP KETOROLAC | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 16, 2022 | DESIPRAMINE | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| December 16, 2022 | INVOKAMET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2022 | AURO-GEFITINIB | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 16, 2022 | MIFISO | Linepharma International Limited | New Drug Submission (NDS) · Other |
| December 16, 2022 | ACT EXEMESTANE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 16, 2022 | ACCUPRIL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 16, 2022 | PANTOPRAZOLE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 15, 2022 | PMS-EZETIMIBE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2022 | APO-AMOXI CLAV | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2022 | DELSTRIGO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2022 | RIVA-OXAZEPAM | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 15, 2022 | APO-QUETIAPINE FUMARATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2022 | PMS-ATOMOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 15, 2022 | KYNMOBI | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2022 | BASAGLAR | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2022 | VAXZEVRIA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2022 | HADLIMA / HADLIMA PUSHTOUCH | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2022 | PIFELTRO | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 14, 2022 | ZIMED PF | Aequus Pharmaceuticals Inc | New Drug Submission (NDS) · Other |
| December 14, 2022 | JAMP PANTOPRAZOLE SODIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 14, 2022 | APO-QUINAPRIL/HCTZ TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 14, 2022 | MIRTAZAPINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 14, 2022 | AG-OLANZAPINE FC; AG-OLANZAPINE ODT | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2022 | INREBIC | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2022 | CTP 30 | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| December 13, 2022 | VIROPTIC | Bausch & Lomb Inc. | New Drug Submission (NDS) · Admin |
| December 13, 2022 | ADALAT XL | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2022 | JAMP DIGOXIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 13, 2022 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2022 | ACLASTA | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| December 13, 2022 | LEUCOVORIN CALCIUM INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2022 | SOMATULINE AUTOGEL | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2022 | ACCURETIC | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2022 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| December 13, 2022 | ESCITALOPRAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 13, 2022 | ACH-TOPIRAMATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 12, 2022 | JCOVDEN | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2022 | AIMOVIG | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 12, 2022 | VENLAFAXINE XR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 12, 2022 | SANDOZ IMATINIB | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| December 12, 2022 | PMS-ZOPICLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2022 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | SIMLANDI | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | CABENUVA; VOCABRIA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | PMS-HYDROCHLOROTHIAZIDE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | HYQVIA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | RIVA-VALACYCLOVIR | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 9, 2022 | VICTOZA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | SAXENDA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | OMEPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 9, 2022 | TARO-PRAVASTATIN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 9, 2022 | SANDOZ ALFACALCIDOL | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 9, 2022 | TIMOPTIC-XE | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| December 9, 2022 | JAMP-LACOSAMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2022 | PMSC-NIFEDIPINE ER | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 9, 2022 | JAMP ALENDRONATE SODIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2022 | JAMP METFORMIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 9, 2022 | TARO-BUPROPION XL | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2022 | DARZALEX; DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2022 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 8, 2022 | MINT-SERTRALINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2022 | MINT-CANDESARTAN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2022 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2022 | PMS-PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2022 | IPG-SIMVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2022 | APO-SITAGLIPTIN/METFORMIN XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 8, 2022 | EMPAVELI | Swedish Orphan Biovitrum Ab (Publ) | New Drug Submission (NDS) · Priority-NAS |
| December 8, 2022 | REDDY-ABIRATERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2022 | IPG-PANTOPRAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2022 | VARILRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2022 | PRIORIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2022 | PRIORIX-TETRA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 7, 2022 | ACH-IMATINIB | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 7, 2022 | EVRYSDI | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2022 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2022 | APO-SITAGLIPTIN MALATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2022 | FULVESTRANT INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 6, 2022 | ESTALIS 140/50; ESTALIS 250/50 | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| December 6, 2022 | ESTRADOT 100; ESTRADOT 25; ESTRADOT 37.5; ESTRADOT 50; ESTRADOT 75 | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| December 6, 2022 | BORTEZOMIB FOR INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2022 | PREHEVBRIO | Vbi Vaccines Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| December 6, 2022 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 6, 2022 | JAMP TELMISARTAN-HCT | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 6, 2022 | MOMETASONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 5, 2022 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2022 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2022 | SOLIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2022 | ICATIBANT INJECTION | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 5, 2022 | TEVA-ICATIBANT | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| December 5, 2022 | APO-TRAVOPROST Z | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2022 | AURO-MODAFINIL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2022 | MAR-FLUCONAZOLE-150 | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 5, 2022 | APO-FLUCONAZOLE-150 | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2022 | CLOTRIMAZOLE TOPICAL | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2022 | DRY-CLOX | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| December 5, 2022 | MINT-ICATIBANT | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| December 5, 2022 | ICATIBANT INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| December 2, 2022 | PROGRAF | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2022 | ADVAGRAF | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2022 | ALDACTONE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 2, 2022 | IPG-CELECOXIB | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 2, 2022 | JAMP-MYCOPHENOLATE CAPSULES | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 2, 2022 | KETOROLAC TROMETHAMINE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 2, 2022 | AURO-FEBUXOSTAT | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| December 1, 2022 | IPG-AZITHROMYCIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2022 | XYDALBA | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2022 | CETIRIZINE HYDROCHLORIDE TABLETS | Vita Health Products Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| December 1, 2022 | NRA-ESCITALOPRAM | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| December 1, 2022 | MIDODRINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| December 1, 2022 | CARBETOCIN INJECTION | Juno Pharmaceuticals Corp. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2022 | BUPIVACAINE INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2022 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| December 1, 2022 | PMS-PREDNISOLONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| December 1, 2022 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2022 | BEOVU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2022 | RIVA-ATORVASTATIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 30, 2022 | ATRIANCE | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| November 30, 2022 | FAMPYRA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2022 | MYLOTARG | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2022 | CLAVULIN | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 30, 2022 | AG-EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2022 | AURO-PANTOPRAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2022 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2022 | SANDOZ LISINOPRIL HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2022 | APO-ARIPIPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 30, 2022 | TOBRAMYCIN INJECTION USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 29, 2022 | ANASTROZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 29, 2022 | APO-SORAFENIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2022 | KETOROLAC TROMETHAMINE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2022 | SANDOZ TELMISARTAN HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2022 | CLARITIN ALLERGY + SINUS; CLARITIN ALLERGY + SINUS EXTRA STRENGTH | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 29, 2022 | TRANEXAMIC ACID INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 29, 2022 | GERMSTOPSQ | Envision Sq Inc. | New Drug Submission (NDS) · Other |
| November 28, 2022 | NGENLA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2022 | NEURACEQ | Isologic Innovative Radiopharmaceuticals Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2022 | JAMP-ANASTROZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2022 | MAR-ROSUVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 28, 2022 | ESAMUZE | Dr Reddys Laboratories Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2022 | RITUXAN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2022 | APO-SORAFENIB | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 28, 2022 | JAMP TOFACITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2022 | TARO-TOFACITINIB | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 28, 2022 | OPSUMIT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2022 | TARO-TOFACITINIB | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 28, 2022 | JAMP TOFACITINIB | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 28, 2022 | CLOLAR | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2022 | APOQUEL | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 28, 2022 | AROVYN | Intervet Canada Corp | Abbreviated New Drug Submission (ANDS) · Other |
| November 25, 2022 | SANDOZ PANTOPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2022 | RIVA-TADALAFIL | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 25, 2022 | TARO-CLARITHROMYCIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 25, 2022 | RIVA-ROSUVASTATIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 25, 2022 | KETOROLAC TROMETHAMINE INJECTION, USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 25, 2022 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 25, 2022 | DOXORUBICIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2022 | AROMASIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2022 | ALOXI | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| November 25, 2022 | PMS-DIGOXIN | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| November 25, 2022 | ONDANSETRON | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 25, 2022 | DIGIFAB | Btg International Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 25, 2022 | ZINC SULFATE INJECTION, USP | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| November 25, 2022 | PMS-TOFACITINIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2022 | AURO-TOFACITINIB | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 25, 2022 | PMS-TOFACITINIB | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 25, 2022 | APO-ASA LD | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| November 25, 2022 | AURO-CELECOXIB | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2022 | LACOSAMIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2022 | TEVA-AZATHIOPRINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 25, 2022 | MAR-CINACALCET | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2022 | CISPLATIN INJECTION | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2022 | JAMP-ESCITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 24, 2022 | JAMP LAMIVUDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2022 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2022 | SOTYKTU | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 24, 2022 | RAVICTI | Horizon Therapeutics Ireland Dac | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2022 | APO-DARIFENACIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2022 | MINT-KETOROLAC | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 24, 2022 | GD-TRANEXAMIC ACID | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 24, 2022 | MOUNJARO | Eli Lilly Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 23, 2022 | DOCETAXEL INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 23, 2022 | AURO-CLINDAMYCIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 23, 2022 | JAMP LENALIDOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 23, 2022 | ABEVMY | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2022 | OMEPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 22, 2022 | VFEND | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2022 | HERCEPTIN SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2022 | APO-MOMETASONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | AURO-DARUNAVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | ACT FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | APO-AMOXI | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2022 | ERTAPENEM FOR INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | TARO-FLUCONAZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | TEVA-FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | VORICONAZOLE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | AVAPRO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2022 | TEVA-MOMETASONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | ALLOPURINOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 22, 2022 | JAMP DIMETHYL FUMARATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 22, 2022 | REBINYN | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2022 | ESOMEPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 21, 2022 | AG-ESCITALOPRAM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 21, 2022 | JAMP-ONDANSETRON | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 21, 2022 | VIIBRYD | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 21, 2022 | REBLOZYL | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 21, 2022 | IPG-ZOPICLONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2022 | JAMP-FLUOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 21, 2022 | OVARELIN | Ceva Animal Health Inc | New Drug Submission (NDS) · Other |
| November 18, 2022 | AVSOLA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2022 | M-CLINDAMYCIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 18, 2022 | M-PRAVASTATIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 18, 2022 | MAR-QUETIAPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 18, 2022 | AG-ONDANSETRON | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 18, 2022 | VALACYCLOVIR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 18, 2022 | VESANOID | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2022 | AURO-SUNITINIB | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 18, 2022 | CITALOPRAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 18, 2022 | ACT PRAMIPEXOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 18, 2022 | VIMOVO | Xediton Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 18, 2022 | THYROKARE | Neogen Corporation | New Drug Submission (NDS) · Other |
| November 18, 2022 | SANDOZ SUNITINIB | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 17, 2022 | XYNTHA; XYNTHA SOLOFUSE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2022 | APO-METHOTREXATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2022 | PMS-ARIPIPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2022 | AURO-CLOPIDOGREL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 17, 2022 | TEMAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 17, 2022 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2022 | METHOTREXATE SUBCUTANEOUS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 16, 2022 | MONTELUKAST | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 16, 2022 | AKYNZEO | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| November 16, 2022 | M-M-R II | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2022 | PROQUAD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2022 | ACH-MYCOPHENOLATE | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 16, 2022 | TECARTUS | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| November 16, 2022 | OCALIVA | Advanz Pharma Canada Inc. | New Drug Submission (NDS) · Admin |
| November 16, 2022 | ACUVAIL | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 16, 2022 | SALOFALK | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 16, 2022 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2022 | APO-FLUCONAZOLE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 16, 2022 | SANDOZ ANASTROZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2022 | DOVATO | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2022 | RIVA-METFORMIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| November 15, 2022 | PMS-CLONAZEPAM | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2022 | VYEPTI | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2022 | SHINGRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2022 | RIVA-ATOMOXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2022 | SERTRALINE-100; SERTRALINE-25; SERTRALINE-50 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2022 | NAT-ESCITALOPRAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 15, 2022 | DARZALEX; DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 15, 2022 | AURO-LURASIDONE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 15, 2022 | PMS-CELECOXIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 15, 2022 | SERTRALINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 14, 2022 | ADACEL | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2022 | APO-MYCOPHENOLIC ACID | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2022 | DIVALPROEX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2022 | ACH-TELMISARTAN HCTZ | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2022 | MINT-METFORMIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | ABRILADA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2022 | POLIVY | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2022 | LYRICA | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 14, 2022 | CLARITHROMYCIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 14, 2022 | SALOFALK | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 14, 2022 | TARO-ANASTROZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 14, 2022 | MAR-APREMILAST | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | MINT-APREMILAST | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | GLN-APREMILAST | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | SANDOZ APREMILAST | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | JAMP APREMILAST | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | AURO-APREMILAST | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | TEVA-APREMILAST | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 14, 2022 | PMS-APREMILAST | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 10, 2022 | ILARIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2022 | VARIVAX III | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2022 | KANJINTI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2022 | LANSOPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 10, 2022 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2022 | ZEMAIRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 10, 2022 | AURO-INDOMETHACIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2022 | CETIRIZINE; CETIRIZINE EXTRA STRENGTH | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2022 | MIRTAZAPINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 10, 2022 | DOCETAXEL INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2022 | VENLAFAXINE XR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2022 | CEFAZOLIN INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2022 | APO-PAROXETINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 10, 2022 | UBRELVY | AbbVie Corporation | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 9, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2022 | EVUSHELD | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2022 | KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION | Curium Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2022 | KADCYLA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2022 | TEVA-TOPIRAMATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 9, 2022 | RESTASIS MULTIDOSE | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 9, 2022 | ARIMIDEX | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 9, 2022 | ERVEBO | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 8, 2022 | CIPROFLOXACIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2022 | MYCOPHENOLIC ACID | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2022 | RBX-CLOPIDOGREL | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| November 8, 2022 | TEVA-SALBUTAMOL STERINEBS P.F. | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2022 | MINT-ATORVASTATIN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| November 8, 2022 | HYDREA | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Admin |
| November 8, 2022 | CAMZYOS | Bristol-Myers Squibb Canada | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 8, 2022 | RIVA-LANSOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2022 | JAMP-LISINOPRIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2022 | BYSTOLIC | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 8, 2022 | ACT FLUOXETINE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 8, 2022 | ACULAR; ACULAR LS | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 8, 2022 | APO-QUETIAPINE XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 8, 2022 | RADICAVA | Mitsubishi Tanabe Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Priority |
| November 8, 2022 | TREMFYA; TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 8, 2022 | TEVA-PROPOFOL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 7, 2022 | VASERETIC | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2022 | MVASI | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 7, 2022 | RIZATRIPTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 7, 2022 | SALOFALK | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 4, 2022 | ZYVOXAM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2022 | FLAMAZINE | Smith & Nephew, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2022 | PULMOZYME | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2022 | CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2022 | CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2022 | MAR-ONDANSETRON | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 4, 2022 | ACTONEL; ACTONEL DR | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| November 4, 2022 | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2022 | ABIRATERONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 4, 2022 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2022 | HYZAAR; HYZAAR DS | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2022 | REDDY-PROGESTERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 4, 2022 | MONOFERRIC | Pharmacosmos A | Supplement to a New Drug Submission (SNDS) · Other |
| November 4, 2022 | MELOXIMED | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| November 3, 2022 | SOFRACORT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2022 | LUTREPULSE | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2022 | CITALOPRAM-10 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 3, 2022 | EXELON | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| November 3, 2022 | LANSOPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 3, 2022 | DENAGARD | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2022 | MICOTIL | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| November 3, 2022 | SPIKEVAX BIVALENT (ORIGINAL/OMICRON BA.4/5) | Modernatx, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| November 2, 2022 | RIVA-CLOPIDOGREL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 2, 2022 | RIVA-ESCITALOPRAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 2, 2022 | APO-LISINOPRIL/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | MICAFUNGIN SODIUM FOR INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| November 2, 2022 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | CIPROFLOXACIN TABLETS USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | CIPROFLOXACIN INTRAVENOUS INFUSION BP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | ONDANSETRON ODT | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 2, 2022 | SUNLENCA | Gilead Sciences Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| November 2, 2022 | ABRAXANE FOR INJECTABLE SUSPENSION | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| November 2, 2022 | PMS-IRON SUCROSE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 2, 2022 | AERIUS; AERIUS KIDS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | REDDY-EVEROLIMUS | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| November 1, 2022 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | DONEPEZIL HYDROCHLORIDE TABLETS USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2022 | DAURISMO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | ELIGARD | Tolmar International Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | OMNITROPE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | MAR-ANASTROZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| November 1, 2022 | CUVPOSA | Medexus Inc | New Drug Submission (NDS) · Admin |
| November 1, 2022 | APO-BRIMONIDINE-TIMOP | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| November 1, 2022 | ULTOMIRIS | Alexion Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | COZAAR | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | 263616; HYZAAR DS | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| November 1, 2022 | JAMP PANTOPRAZOLE SODIUM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2022 | EDARBYCLOR | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2022 | GLYCOPYRROLATE INJECTION USP | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2022 | PROLOPA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2022 | APO-BRIMONIDINE-TIMOP | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 31, 2022 | APO-BRIMONIDINE-TIMOP | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 31, 2022 | OXY.IR | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| October 31, 2022 | JAMP VALPROIC ACID ORAL SOLUTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 28, 2022 | PREGABALIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 28, 2022 | NRA-EZETIMIBE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 28, 2022 | MAR-METFORMIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 28, 2022 | CEFTIN | Sandoz Canada Inc. | New Drug Submission (NDS) · Admin |
| October 28, 2022 | MYLAN-MIRTAZAPINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 28, 2022 | SEEBRI BREEZHALER | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2022 | JAMP-BRIMONIDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 28, 2022 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2022 | ZONTIVITY | Xspire Pharma, Llc | New Drug Submission (NDS) · Admin |
| October 28, 2022 | HIZENTRA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 28, 2022 | SUMATRIPTAN INJECTION, USP | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| October 28, 2022 | PACLITAXEL INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 28, 2022 | APO-TAMSULOSIN CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 28, 2022 | SANDOZ TACROLIMUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 28, 2022 | TOPIRAMATE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 27, 2022 | TARO-VENLAFAXINE XR | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 27, 2022 | TRESIBA | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2022 | ESTRACE | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| October 27, 2022 | RBX-CELECOXIB | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| October 27, 2022 | JCOVDEN | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2022 | AIMOVIG | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 27, 2022 | ACTEMRA SC | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2022 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2022 | RELPAX | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2022 | CIPROFLOXACIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 26, 2022 | PRO-VALACYCLOVIR | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 26, 2022 | MAR-CITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 26, 2022 | ESTRADIOL | Pharmascience Inc. | New Drug Submission (NDS) · Admin |
| October 26, 2022 | CLARITHROMYCIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 26, 2022 | TEVA-RISPERIDONE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| October 26, 2022 | MAJEPTIL | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 26, 2022 | MAR-KETOROLAC | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 26, 2022 | AMLODIPINE BESYLATE TABLETS | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 26, 2022 | ACT VENLAFAXINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 26, 2022 | LEQVIO | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2022 | SANDOZ IRBESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 26, 2022 | KINERET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2022 | CELECOXIB | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 26, 2022 | MANDELAMINE | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 26, 2022 | AMSA PD | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 26, 2022 | ACT ZOPICLONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 26, 2022 | BRAVECTO | Intervet Canada Corp | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2022 | TAGAMET PREVENT | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 26, 2022 | ELONOX; ELONOX HP | Fresenius Kabi Canada Ltd | New Drug Submission (NDS) · Other |
| October 26, 2022 | PMS-AZACITIDINE FOR INJECTION | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 25, 2022 | MICRO +6 CONCENTRATE; MICRO +6 PEDIATRIC | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2022 | TIMOPTIC | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2022 | LASIX SPECIAL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2022 | PMS-CLONAZEPAM-R | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2022 | FEMARA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2022 | ZADITEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 25, 2022 | TEVA-ZOPICLONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2022 | AURO-ESCITALOPRAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 25, 2022 | APO-BIMATOPROST | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2022 | JAMP-CITALOPRAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 24, 2022 | ZIRABEV | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 24, 2022 | SINCALIDE FOR INJECTION | Avir Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2022 | TEVA-SPIRONOLACTONE/HCTZ | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 24, 2022 | PLAVIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 24, 2022 | IMITREX; IMITREX DF; IMITREX NASAL SPRAY | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN-METFORMIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN/METFORMIN XR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN/METFORMIN XR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2022 | BISOPROLOL TABLETS | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| October 24, 2022 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN MALATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN MALATE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN-METFORMIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2022 | APO-SITAGLIPTIN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 24, 2022 | HANZEMA | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2022 | REZUROCK | Sanofi-Aventis Canada Inc. | New Drug Submission (NDS) · Labelling Only |
| October 21, 2022 | COMIRNATY ORIGINAL/OMICRON BA.1 | Biontech Manufacturing Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 21, 2022 | KEVZARA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2022 | CARMUSTINE FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 21, 2022 | IBUPROFEN EXTRA STRENGTH CAPLETS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2022 | COVERSYL PLUS; COVERSYL PLUS HD; COVERSYL PLUS LD | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2022 | TEVA-VENLAFAXINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2022 | COVERSYL | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2022 | VIACORAM | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 21, 2022 | MITOMYCIN FOR INJECTION, USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| October 21, 2022 | OXALIPLATIN INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 21, 2022 | MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 21, 2022 | AUDRINA 21; AUDRINA 28 | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 20, 2022 | PREZCOBIX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2022 | SYMTUZA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 20, 2022 | M-CITALOPRAM | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 20, 2022 | IPG-ROSUVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2022 | JAMP RIZATRIPTAN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2022 | CHOLEDYL | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 20, 2022 | JAMP-CETIRIZINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 20, 2022 | APO-BROMAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| October 20, 2022 | TARO-DESVENLAFAXINE | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| October 20, 2022 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2022 | ACT CLOPIDOGREL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2022 | AURO-LAMOTRIGINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2022 | PMS-RANITIDINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2022 | CHLOROMYCETIN SUCCINATE INJECTION | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 20, 2022 | PANECTYL | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 20, 2022 | JAMP ABIRATERONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 20, 2022 | GONAVET | Modern Veterinary Therapeutics Llc | New Drug Submission (NDS) · Other |
| October 19, 2022 | ERFA-TRANEXAMIC | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 19, 2022 | ZOLOFT | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2022 | CANDESARTAN HCT | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 19, 2022 | FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2022 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 19, 2022 | AURO-ZIPRASIDONE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2022 | AURO-CITALOPRAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2022 | JAMP METHIMAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2022 | HEPAGAM B | Ki Biopharma Llc | New Drug Submission (NDS) · Labelling Only |
| October 19, 2022 | TEVA-TICAGRELOR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 19, 2022 | JAMP LEVETIRACETAM TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2022 | EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES; IBUPROFEN LIQUID GEL CAPSULES | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 18, 2022 | IVOZFO | Verity Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2022 | JAMP AMIODARONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 18, 2022 | CONSTELLA | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| October 18, 2022 | RIZATRIPTAN RDT | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 18, 2022 | HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 18, 2022 | EVUSHELD | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 17, 2022 | LEVETIRACETAM | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 17, 2022 | JAMP-OLOPATADINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 14, 2022 | PRIVIGEN | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2022 | PREZISTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2022 | TIVICAY | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2022 | INTELENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2022 | PMS-ZOLPIDEM ODT | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 14, 2022 | KERENDIA | Bayer Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 14, 2022 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2022 | PARSITAN 50 | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 14, 2022 | JAMP-CELECOXIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 14, 2022 | NORLUTATE | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 14, 2022 | NABUMETONE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 14, 2022 | ORCIPRENALINE | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 14, 2022 | CERUBIDINE | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 14, 2022 | ERFA-AMIKACIN | Searchlight Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 14, 2022 | ATARAX | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 14, 2022 | VYNDAQEL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 14, 2022 | PRZ-AMOXICILLIN | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 14, 2022 | VINCRISTINE SULFATE INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | ADEMPAS | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | ILLUCCIX | Telix Pharmaceuticals (Us) Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 13, 2022 | PROQUAD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | NEXPLANON | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | ARAVA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | NINLARO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | PMS-CIPROFLOXACIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 13, 2022 | JAMP-LEVETIRACETAM | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 13, 2022 | KADCYLA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | AA-METOPROLOL SR | AA Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| October 13, 2022 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 13, 2022 | MINT-MEMANTINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| October 12, 2022 | TEVA-CITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2022 | BORTEZOMIB FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2022 | PRZ-METFORMIN | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 12, 2022 | SARCLISA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2022 | AG-DONEPEZIL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 12, 2022 | RACTOPAMINE 20 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2022 | NAT-LANTHANUM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2022 | GLN-OLMESARTAN HCTZ | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2022 | MINT-RISPERIDON | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 12, 2022 | LUNESTA | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2022 | REBINYN (NONACOG BETA PEGOL) | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 12, 2022 | RACTOPAMINE 4 | Bio Agri Mix Lp | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2022 | NATCO-CITALOPRAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2022 | TRUMENBA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2022 | HYRIMOZ | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2022 | INREBIC | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 11, 2022 | MINT-ARIPIPRAZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2022 | BORTEZOMIB FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2022 | SANDOZ PRAMIPEXOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 11, 2022 | AURO-LEVOCARB | Auro Pharma Inc. | New Drug Submission (NDS) · Other |
| October 11, 2022 | BIMEPRAZOL | Bimeda-MTC Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 7, 2022 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2022 | ORFADIN | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2022 | REMICADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2022 | AG-SERTRALINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 7, 2022 | CEREBYX | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 7, 2022 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| October 7, 2022 | RIVA-IRBESARTAN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 7, 2022 | PMS-BORTEZOMIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2022 | XYREM | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2022 | SANDOZ ALENDRONATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 7, 2022 | SUMMIT ULTRA | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2022 | CLOTRIMAZOLE TOPICAL | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 7, 2022 | PMS-PIRFENIDONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| October 7, 2022 | COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 | Biontech Manufacturing Gmbh | New Drug Submission (NDS) · New Active Substance (NAS) |
| October 6, 2022 | METHOTREXATE SUBCUTANEOUS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2022 | ASA 81 MG | Laboratoires Trianon Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 6, 2022 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2022 | COMBIGAN | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| October 6, 2022 | APRI 21; APRI 28 | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2022 | OXALIPLATIN INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 6, 2022 | BAMBEVI | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2022 | TRODELVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 5, 2022 | SPORANOX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2022 | SERTRALINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2022 | AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2022 | LEDERLE LEUCOVORIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2022 | JAMP GLICLAZIDE-MR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2022 | TARO-PHENYTOIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2022 | ONDANSETRON INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2022 | NARDIL | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| October 4, 2022 | TRANEXAMIC ACID INJECTION (AMPOULES); TRANEXAMIC ACID INJECTION (BULK VIALS); TRANEXAMIC ACID INJECTION (VIALS) | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2022 | LOKELMA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2022 | MICARDIS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2022 | TWYNSTA | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2022 | MICARDIS PLUS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| October 4, 2022 | SANDOZ TACROLIMUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2022 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2022 | TIZANIDINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 4, 2022 | NRA-APIXABAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2022 | NRA-APIXABAN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 4, 2022 | RIVA APIXABAN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 4, 2022 | RIVA APIXABAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| October 3, 2022 | ACT CITALOPRAM | Sunovion Pharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2022 | FOCLIVIA | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2022 | ICLUSIG | Takeda Pharmaceuticals U.S.A., Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2022 | SERTRALINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 3, 2022 | JAMP-ATORVASTATIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| October 3, 2022 | EXELON PATCH 10; EXELON PATCH 15; EXELON PATCH 5 | Knight Therapeutics Inc. | New Drug Submission (NDS) · Admin |
| October 3, 2022 | BOTOX COSMETIC | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2022 | BOTOX | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| October 3, 2022 | APO-VARENICLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| October 3, 2022 | TEVA-ATORVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2022 | CAYSTON | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2022 | ALPHAGAN | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| September 29, 2022 | VIRAZOLE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2022 | NUBEQA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| September 29, 2022 | ROCURONIUM BROMIDE INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2022 | IPG-QUETIAPINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2022 | AURO-CLOZAPINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2022 | DICLOFENAC SODIUM SOLUTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 29, 2022 | PMS-SULFASALAZINE; PMS-SULFASALAZINE-E.C | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2022 | IPG-TRAMADOL/ACET | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2022 | AZITHROMYCIN FOR INJECTION, USP | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 29, 2022 | PMS-TRAMADOL-ACET | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 29, 2022 | FML | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2022 | LASIX ORAL SOLUTION | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2022 | MINOX | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 29, 2022 | LEO PHARMA - TACROLIMUS | Leo Pharma Gen, A Division Of Leo Pharma Inc. | New Drug Submission (NDS) · Labelling Only |
| September 28, 2022 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| September 28, 2022 | PMS-MOXIFLOXACIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2022 | LABETALOL HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 28, 2022 | FOQUEST | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2022 | YESCARTA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2022 | LUCENTIS | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 28, 2022 | NRA-ATORVASTATIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 28, 2022 | NEXAVAR | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2022 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2022 | PREGABALIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 26, 2022 | MIRENA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2022 | GEMCITABINE INJECTION | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2022 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2022 | TEVETEN PLUS | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2022 | CALCITRIOL CAPSULES | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2022 | DIFLUNISAL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2022 | TEVA-VORICONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 26, 2022 | ALKERAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 26, 2022 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 23, 2022 | XELODA | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Admin |
| September 23, 2022 | DICLOFENAC TOPICAL SOLUTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2022 | QUETIAPINE XR | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| September 23, 2022 | NRA-CANDESARTAN HCTZ | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 23, 2022 | TARO-BORTEZOMIB | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2022 | ACH-APIXABAN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2022 | TRIUMEQ | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2022 | PEMETREXED DISODIUM FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2022 | ACH-APIXABAN | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 23, 2022 | MINT-CELECOXIB | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2022 | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2022 | GARDASIL 9 | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2022 | TEVA-RASAGILINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 23, 2022 | BORTEZOMIB FOR INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 23, 2022 | TEVA-DEFERASIROX (TYPE J) | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 22, 2022 | XEOMIN; XEOMIN COSMETIC | Merz Pharmaceuticals Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2022 | SEMGLEE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2022 | NRA-LEVETIRACETAM | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2022 | LITHANE | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| September 22, 2022 | APO-FLUVOXAMINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 22, 2022 | LUPIN-ESTRADIOL | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | SANDOZ LINEZOLID | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | NAPROXEN-NA; NAPROXEN-NA DF | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| September 22, 2022 | ACYCLOVIR SODIUM INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 22, 2022 | TARO-PANTOPRAZOLE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 22, 2022 | M-MOXIFLOXACIN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 22, 2022 | ONDANSETRON ODT | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2022 | AUBAGIO | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2022 | RIVASA 81 MG EC | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2022 | 24HR NASAL ALLERGY RELIEF | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | LABETALOL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | APO-DICLO; APO-DICLO SR | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2022 | NAT-LEVETIRACETAM | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 22, 2022 | ALLOPURINOL-100; ALLOPURINOL-200; ALLOPURINOL-300 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| September 22, 2022 | PAXIL CR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2022 | PAXIL | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 22, 2022 | IRINOTECAN HYDROCHLORIDE INJECTION, USP | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | CEFAZOLIN FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | PMS-DICLOFENAC-MISOPROSTOL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | BUPRENOL | Champion Alstoe Animal Health Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 22, 2022 | ETODOLAC | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 22, 2022 | TEVA-LENALIDOMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 21, 2022 | TALTZ | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2022 | DOVATO | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2022 | INFLUVAC TETRA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2022 | METRONIDAZOLE INJECTION, USP | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 21, 2022 | PRAVASTATIN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 21, 2022 | PMS-CITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2022 | JAMP ABACAVIR / LAMIVUDINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 21, 2022 | RYALTRIS | Glenmark Specialty Sa | New Drug Submission (NDS) · Other |
| September 20, 2022 | MINT-APIXABAN | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | AG-APIXABAN | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2022 | PENTHROX | Endo Ventures Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2022 | M-APIXABAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2022 | BIO-APIXABAN | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2022 | JAMP APIXABAN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | PRO-APIXABAN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2022 | APIXABAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| September 20, 2022 | TEVA-APIXABAN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2022 | SANDOZ APIXABAN TABLET | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2022 | SANDOZ APIXABAN SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2022 | TARO-APIXABAN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | SANDOZ APIXABAN SDZ | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | TEVA-APIXABAN | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 20, 2022 | NAT-APIXABAN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2022 | NAT-APIXABAN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2022 | MAR-APIXABAN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 20, 2022 | MAR-APIXABAN | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | AURO-APIXABAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | SANDOZ APIXABAN TABLET | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 20, 2022 | NAT-APIXABAN | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 16, 2022 | JEMPERLI | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | OCALIVA | Intercept Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | IRINOTECAN HYDROCHLORIDE INJECTION USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2022 | CYCLOPHOSPHAMIDE FOR INJECTION | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| September 16, 2022 | JAMP-ASA 81 MG EC | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2022 | LABETALOL HYDROCHLORIDE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2022 | OZURDEX | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | MICRO PLUS 4 REGULAR STRENGTH | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | JAMP PAROXETINE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2022 | ACUVAIL | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | M-SERTRALINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| September 16, 2022 | VIMPAT | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | HUMIRA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | NOZINAN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 16, 2022 | FENTANYL CITRATE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2022 | AG-TOPIRAMATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 16, 2022 | JAMP ONDANSETRON | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2022 | APO-ONDANSETRON | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 16, 2022 | M-AMOXI CLAV | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 15, 2022 | NASACORT AQ | Sanofi Consumer Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | NUCALA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | DILTIAZEM HYDROCHLORIDE INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 15, 2022 | FULVESTRANT INJECTABLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 15, 2022 | FIBRYGA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | LIVTENCITY | Takeda Canada Incorporated | New Drug Submission (NDS) · Priority-NAS |
| September 15, 2022 | DIGOXIN INJECTION C.S.D. | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | LOLO | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | DUAKLIR GENUAIR | Covis Pharma Gmbh | New Drug Submission (NDS) · Admin |
| September 15, 2022 | MYLAN-ONDANSETRON | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2022 | CEFAZOLIN SODIUM FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2022 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | NETILDEX (WITH PRESERVATIVE); NETILDEX (WITHOUT PRESERVATIVE) | Sifi S.P.A. | New Drug Submission (NDS) · Admin |
| September 15, 2022 | APO-LANSOPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 15, 2022 | AG-ROSUVASTATIN CALCIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 15, 2022 | SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 15, 2022 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | APRESOLINE | Sterimax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 15, 2022 | GABAPENTIN CAPSULES | Granules India Limited | Abbreviated New Drug Submission (ANDS) · Other |
| September 15, 2022 | METHOFILL SELF-DOSE INJECTOR | Accord Healthcare Inc | New Drug Submission (NDS) · Other |
| September 15, 2022 | MINT-ONDANSETRON SOLUTION | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | TAMIFLU | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2022 | TEVA-ESCITALOPRAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | SANDOZ MOMETASONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | PMS-DOXYLAMINE-PYRIDOXINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | APO-TRAMADOL/ACET | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2022 | APO-ONDANSETRON | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | SUSVIMO | Hoffmann-La Roche Limited | New Drug Submission (NDS) · Other |
| September 14, 2022 | RIVA-HYDROXYUREA | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| September 14, 2022 | LINEZOLID INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | INREBIC | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 14, 2022 | IRINOTECAN HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 14, 2022 | APOQUEL | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2022 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2022 | RAPAMUNE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2022 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| September 13, 2022 | PMS-VALACYCLOVIR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2022 | CEFAZOLIN FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2022 | APO-SERTRALINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2022 | SANDOZ SILODOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2022 | ACT LATANOPROST/TIMOLOL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 13, 2022 | APO-METHYLPHENIDATE ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2022 | FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2022 | TUDORZA GENUAIR | Covis Pharma Gmbh | New Drug Submission (NDS) · Admin |
| September 12, 2022 | TARO-ATORVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 12, 2022 | DARZALEX; DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2022 | IDARUBICIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2022 | SANDOZ LOSARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2022 | M-ESOMEPRAZOLE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 12, 2022 | ACT TERBINAFINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2022 | APO-FINASTERIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 12, 2022 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2022 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2022 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 12, 2022 | AURO-ONDANSETRON ODT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 12, 2022 | IBUPROFEN 200 MG; IBUPROFEN 400 MG | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2022 | AMGEVITA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2022 | BOTOX COSMETIC | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| September 9, 2022 | DEPO-PROVERA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2022 | BOTOX | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| September 9, 2022 | TRANEXAMIC ACID INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2022 | LUTATHERA | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2022 | DEFINITY | Lantheus Mi Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2022 | MINT-TOPIRAMATE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2022 | AURO-TRAMADOL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2022 | LUMIGAN RC | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| September 9, 2022 | AURO-TRAMADOL/ACETAMINOPHEN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2022 | TRELSTAR | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 9, 2022 | SANDOZ SILODOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 9, 2022 | VRAYLAR | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| September 9, 2022 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2022 | FLUOXETINE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| September 8, 2022 | PMS-AMANTADINE HYDROCHLORIDE CAPSULES; PMS-AMANTADINE HYDROCHLORIDE SYRUP | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| September 8, 2022 | TRANEXAMIC ACID | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 8, 2022 | M-LEVETIRACETAM | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 8, 2022 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2022 | CEFAZOLIN FOR INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2022 | MINT-ANASTROZOLE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2022 | FULPHILA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| September 8, 2022 | EYEZIRGAN | Laboratoires Théa | New Drug Submission (NDS) · Other |
| September 8, 2022 | IPG-ANASTROZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 8, 2022 | SANDOZ ANASTROZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 7, 2022 | IPG-ESCITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 6, 2022 | INFANRIX HEXA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2022 | BOOSTRIX-POLIO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2022 | BOOSTRIX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2022 | TARO-ESCITALOPRAM | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| September 6, 2022 | OPSUMIT | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2022 | OPSYNVI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 6, 2022 | MINT-QUETIAPINE XR | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2022 | RYLAZE | Jazz Pharmaceuticals Ireland Limited | New Drug Submission (NDS) · Other |
| September 2, 2022 | GLEEVEC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | OSPHENA | Duchesnay Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | MONOFERRIC | Pharmacosmos A | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | GD-DICLOFENAC/MISOPROSTOL 50; GD-DICLOFENAC/MISOPROSTOL 75 | Genmed A Division Of Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2022 | JAMP POSACONAZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| September 2, 2022 | JULUCA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | DIARRHEA RELIEF | Vita Health Products Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | TEVA-PREGABALIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2022 | PENTAMIDINE ISETIONATE FOR INJECTION BP | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 2, 2022 | TEVA-GEMFIBROZIL | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | NASACORT ALLERGY 24HR | Sanofi Consumer Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 2, 2022 | CARBOPROST TROMETHAMINE INJECTION USP | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| September 2, 2022 | SILEO | Orion Corporation | New Drug Submission (NDS) · Other |
| September 1, 2022 | SUBLINOX | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2022 | VALTREX | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2022 | DEFINITY | Lantheus Mi Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2022 | TICLOPIDINE | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| September 1, 2022 | BELKYRA | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| September 1, 2022 | AG-ALLOPURINOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| September 1, 2022 | EDARBI | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| September 1, 2022 | TENOXICAM | AA Pharma Inc. | New Drug Submission (NDS) · Admin |
| September 1, 2022 | LOLO | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| September 1, 2022 | MYLAN-AZELASTINE/FLUTICASONE | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| September 1, 2022 | MINT-ESCITALOPRAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2022 | MINT-CIPROFLOX | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2022 | TARO-CLOMIPRAMINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| September 1, 2022 | SPIKEVAX BIVALENT | Modernatx, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 31, 2022 | RYMTI | Lupin Pharma Canada Limited | New Drug Submission (NDS) · Other |
| August 31, 2022 | ODAN BUPROPION SR | Odan Laboratories Ltd. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 31, 2022 | ACTIVASE RT-PA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2022 | ONDISSOLVE ODF | Takeda Canada Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 31, 2022 | VYXEOS | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2022 | TEVA-PIROXICAM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 31, 2022 | KOSELUGO | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 31, 2022 | TEVA-CINACALCET | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2022 | AURO-METFORMIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2022 | IPG-ONDANSETRON | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 30, 2022 | SULFAMETHOXAZOLE AND TRIMETHOPRIM INJECTION, BP | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| August 30, 2022 | WAYMADE-NAPROXEN | Waymade Plc | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2022 | LIXIANA | Servier Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 30, 2022 | MAR-MODAFINIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 30, 2022 | NRA-CETIRIZINE TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 30, 2022 | JAMP-ALLOPURINOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 30, 2022 | MODAFINIL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 29, 2022 | ALEMBIC-LACOSAMIDE | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2022 | MAR-ABIRATERONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2022 | TEVA-QUETIAPINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 29, 2022 | NAT-EVEROLIMUS | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| August 29, 2022 | ALPHAGAN P | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 29, 2022 | OZURDEX | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 29, 2022 | RIVA-SERTRALINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 29, 2022 | FETZIMA | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 29, 2022 | FML | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 29, 2022 | LATISSE | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 26, 2022 | BASAGLAR | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2022 | PEDIAPRED | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2022 | PMS-LAMOTRIGINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 26, 2022 | ACULAR; ACULAR LS | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2022 | NEORAL; SANDIMMUNE I.V. | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2022 | BRIVLERA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 26, 2022 | TULAXXIN | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| August 25, 2022 | ATORVASTATIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2022 | SUNOSI | Axsome Malta Ltd. | New Drug Submission (NDS) · Admin |
| August 25, 2022 | FLUVOXAMINE TABLETS | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| August 25, 2022 | ACH-ESCITALOPRAM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2022 | AZOPT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2022 | PLUVICTO | Advanced Accelerator Applications Usa, Inc. | New Drug Submission (NDS) · Priority-NAS |
| August 25, 2022 | SANDOZ LOSARTAN HCT; SANDOZ LOSARTAN HCT DS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2022 | PIQRAY | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2022 | ENTROPHEN | Pendopharm Division Of Pharmascience Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 25, 2022 | TRULICITY | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 25, 2022 | MONOVET | Huvepharma Eood | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2022 | CONRAY 60 | Liebel-Flarsheim Company Llc | New Drug Submission (NDS) · Labelling Only |
| August 24, 2022 | ALENDRONATE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2022 | SANDOZ MIGLUSTAT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2022 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 24, 2022 | ONDANSETRON | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 24, 2022 | NAT-DARUNAVIR | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2022 | ENTECAVIR TABLETS | Strides Pharma Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 24, 2022 | MYLAN-PERINDOPRIL/INDAPAMIDE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2022 | LIDOCAINE HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2022 | NRA-FLECAINIDE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 23, 2022 | JAMP PIRFENIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 23, 2022 | RIVA-CLINDAMYCIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2022 | METACAM 40 MG/ML | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 23, 2022 | M-ATORVASTATIN | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 23, 2022 | ARIPIPRAZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 22, 2022 | TEVA-NAPROXEN; TEVA-NAPROXEN EC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 22, 2022 | NRA-SERTRALINE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 22, 2022 | JAMP-PAROXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 22, 2022 | TRI-CIRA 21; TRI-CIRA 28 | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2022 | SANDOZ TAMSULOSIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2022 | LAMISIL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2022 | AG-ALENDRONATE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 19, 2022 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 19, 2022 | ANASTROZOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| August 19, 2022 | SANDOZ TAMSULOSIN CR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 19, 2022 | PLERIXAFOR INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 19, 2022 | DANTROLENE SODIUM FOR INJECTION, USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| August 19, 2022 | ATORVASTATIN | Dr Reddys Laboratories Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 19, 2022 | APO-NAPRO-NA; APO-NAPRO-NA DS | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2022 | BRIVLERA | Ucb Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2022 | INCLUNOX; INCLUNOX HP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2022 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2022 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Priority |
| August 18, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2022 | AVENTYL | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2022 | MAR-ONDANSETRON ODT | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2022 | PERSANTINE | Glenwood Gmbh Pharmazeutische Erzeugnisse | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2022 | APO-TRAMADOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 18, 2022 | CITALOPRAM - 20; CITALOPRAM - 40 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2022 | AG-PAROXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2022 | M-PAROXETINE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2022 | ASA EC | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 18, 2022 | ACET 120; ACET 160; ACET 325; ACET 650 | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 18, 2022 | DRY-CLOX | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2022 | VYNDAMAX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2022 | PREZISTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2022 | PREZCOBIX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2022 | APO-CELECOXIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2022 | SANDOZ PIRFENIDONE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 17, 2022 | SYMTUZA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2022 | JADENU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2022 | EXJADE | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 17, 2022 | ROCURONIUM BROMIDE INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 16, 2022 | TEVA-TIAPROFENIC ACID | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2022 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2022 | MOVISSE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2022 | CERVIDIL | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2022 | INHIBACE PLUS | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2022 | PROPOFOL INJECTION | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 16, 2022 | COMPUDOSE | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2022 | TEMODAL | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 16, 2022 | OCUFLOX | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 16, 2022 | KORSUVA | Vifor Fresenius Medical Care Renal Pharma Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| August 15, 2022 | AVONEX | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2022 | BAVENCIO | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2022 | REACTINE (10 MG); REACTINE (5 MG); REACTINE (CHILDREN'S SYRUP); REACTINE ALLERGY; REACTINE ALLERGY LIQUID GELS; REACTINE FAST MELT JUNIOR; REACTINE RAPID DISSOLVE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 15, 2022 | ZYMAR | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 15, 2022 | PMS-OLMESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 15, 2022 | ONDANSETRON INJECTION USP; ONDANSETRON INJECTION USP (PRESERVATIVE FREE) | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 15, 2022 | JAMP RABEPRAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 15, 2022 | AMPROLIUM SOLUTION | Bio Agri Mix Lp | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2022 | NUVAXOVID | Novavax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2022 | HULIO | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2022 | AG-METOPROLOL-L | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 12, 2022 | CARVEDILOL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 12, 2022 | M-DARUNAVIR | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 12, 2022 | MAR-MYCOPHENOLIC ACID | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2022 | LIDOCAINE HYDROCHLORIDE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| August 12, 2022 | M-TICAGRELOR | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| August 12, 2022 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2022 | TEVA-SUMATRIPTAN; TEVA-SUMATRIPTAN DF | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2022 | TEVA-LISINOPRIL/HCTZ (TYPE Z) | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 12, 2022 | PMS-PREGABALIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 11, 2022 | REDESCA; REDESCA HP | Shenzhen Techdow Pharmaceutical Co., Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2022 | ERELZI | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2022 | EPCLUSA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2022 | OCALIVA | Intercept Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2022 | XOLAIR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2022 | VYEPTI | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2022 | TEVA-SULINDAC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| August 11, 2022 | DRAXXIN 25 | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2022 | BYSTOLIC | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2022 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2022 | NRA-TELMISARTAN HCTZ | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 10, 2022 | NRA-TELMISARTAN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 10, 2022 | JAMP-ALENDRONATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 10, 2022 | INCRELEX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 10, 2022 | AMIODARONE HYDROCHLORIDE FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2022 | APO-OLMESARTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 10, 2022 | SANDOZ CLARITHROMYCIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2022 | DESCOVY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2022 | PARIET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2022 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 9, 2022 | CABAZITAXEL FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2022 | AG-VARDENAFIL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 9, 2022 | TEVA-ABIRATERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2022 | DOM-MELOXICAM | Dominion Pharmacal | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 9, 2022 | SOM-PAM | Biomed Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2022 | OCTASA | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| August 8, 2022 | RESTASIS | AbbVie Corporation | New Drug Submission (NDS) · Admin |
| August 8, 2022 | AG-SIMVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 8, 2022 | ICLUSIG | Takeda Pharmaceuticals U.S.A., Inc. | New Drug Submission (NDS) · Admin |
| August 8, 2022 | M-SOLIFENACIN SUCCINATE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| August 8, 2022 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 5, 2022 | IPG-CITALOPRAM | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 5, 2022 | ESPEROCT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2022 | JCOVDEN | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2022 | MAYZENT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2022 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 5, 2022 | MED-EXEMESTANE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 5, 2022 | FLUCONAZOLE 150 | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2022 | JAMP ABIRATERONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| August 4, 2022 | MINT-CITALOPRAM | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2022 | IRBESARTAN | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 4, 2022 | AG-MOXIFLOXACIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 4, 2022 | PMS-METHOTREXATE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 4, 2022 | IMIPENEM AND CILASTATIN FOR INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 3, 2022 | MYXREDLIN | Baxter Corporation | New Drug Submission (NDS) · Other |
| August 3, 2022 | FLUCONAZOLE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2022 | MICRO MN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2022 | REVLIMID | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2022 | SANDOZ ESCITALOPRAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2022 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2022 | JEVTANA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2022 | PLERIXAFOR INJECTION | Fresenius Kabi Canada Ltd | Abbreviated New Drug Submission (ANDS) · Other |
| August 2, 2022 | MAR-PAROXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| August 2, 2022 | APO-SUMATRIPTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2022 | ACH-ATORVASTATIN CALCIUM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2022 | CLOTRIMADERM-FLUCONAZOLE COMBI-PACK; FLUCONAZOLE 150 | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2022 | CLOTRIMAZOLE-FLUCONAZOLE COMBI; EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI; FLUCONAZOLE 150 | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| August 2, 2022 | ENTROPHEN CHEWABLE | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| August 2, 2022 | S&S SANITIZER | Ecolab Co. | New Drug Submission (NDS) · Other |
| August 2, 2022 | EXELERATE CSD 15 | Ecolab Co. | New Drug Submission (NDS) · Other |
| August 2, 2022 | CLEANING SANITIZER AND DISINFECTANT RTU | Ecolab Co. | New Drug Submission (NDS) · Other |
| July 29, 2022 | TEVA-DIMETHYL FUMARATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2022 | AZACITIDINE FOR INJECTION | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 29, 2022 | GEN-CLOZAPINE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 29, 2022 | SIMPONI I.V. | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2022 | TORISEL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 29, 2022 | JAMP-TOPIRAMATE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 29, 2022 | SANDOZ TOPIRAMATE TABLETS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 29, 2022 | SANDOZ ESOMEPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 29, 2022 | EMAVERT | Dechra Regulatory Bv | Abbreviated New Drug Submission (ANDS) · Other |
| July 28, 2022 | VERAPAMIL HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2022 | EVUSHELD | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2022 | ROZLYTREK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2022 | DANTRIUM CAPSULES | Endo Par Innovation Company, Llc | Supplement to a New Drug Submission (SNDS) · Other |
| July 28, 2022 | TEZSPIRE | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 27, 2022 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 27, 2022 | AG-PERINDOPRIL ERBUMINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 27, 2022 | MAR-CIPROFLOXACIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 27, 2022 | DARUNAVIR | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 27, 2022 | AURO-VORICONAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 27, 2022 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 26, 2022 | CONSTELLA | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2022 | APO-SOTALOL | Apotex Inc. | New Drug Submission (NDS) · Admin |
| July 26, 2022 | JAMP ENALAPRIL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 26, 2022 | M-FLUOXETINE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 26, 2022 | RIVA-LEVETIRACETAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2022 | AMIKACIN SULFATE INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 26, 2022 | ONDANSETRON INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 26, 2022 | MEKINIST | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 26, 2022 | TAFINLAR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2022 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2022 | SUPEMTEK | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 25, 2022 | AZITHROMYCIN FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 25, 2022 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2022 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 22, 2022 | DIFLUCAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2022 | LAPELGA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2022 | TARO-IMIPENEM-CILASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 22, 2022 | SANDOZ IMATINIB | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 22, 2022 | M-ALENDRONATE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 22, 2022 | PACLITAXEL INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 22, 2022 | DULOXETINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 22, 2022 | DENAGARD | Elanco Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 22, 2022 | JAMP MINOXIDIL SOLUTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 21, 2022 | BURINEX | Karo Pharma Ab | New Drug Submission (NDS) · Admin |
| July 21, 2022 | DIFLUCAN ONE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2022 | ORENCIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 21, 2022 | JAMP-FLUCONAZOLE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2022 | RIVA-FLUCONAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2022 | NAPROXEN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2022 | AG-FLUOXETINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2022 | APO-VALACYCLOVIR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 21, 2022 | AG-FINASTERIDE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 21, 2022 | TRANEXAMIC ACID INJECTION, USP | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2022 | TRURAPI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2022 | ALUNBRIG | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| July 20, 2022 | APO-DABIGATRAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2022 | AURO-ATORVASTATIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 20, 2022 | CESAMET | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2022 | AZARGA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2022 | APO-PERINDOPRIL-INDAPAMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2022 | NORDITROPIN FLEXPRO | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2022 | CABAZITAXEL FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 19, 2022 | MIDAZOLAM INJECTION, USP | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 19, 2022 | RESONIUM CALCIUM | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 19, 2022 | TEVA-NAPROXEN SODIUM; TEVA-NAPROXEN SODIUM DS | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2022 | MAR-ALLOPURINOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 18, 2022 | LUTATHERA | Advanced Accelerator Applications Usa, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2022 | WELLBUTRIN SR | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2022 | TRILEPTAL | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 18, 2022 | OCALIVA | Intercept Pharma Canada Inc. | New Drug Submission (NDS) · Admin |
| July 18, 2022 | MOXIFLOXACIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 18, 2022 | APO-CLONAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 18, 2022 | CAPECITABINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 18, 2022 | LISINOPRIL | Sivem Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| July 18, 2022 | APO-DICLO RAPIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 18, 2022 | ENALAPRIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 15, 2022 | PMS-SERTRALINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2022 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | Bausch & Lomb Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 15, 2022 | LINEZOLID INJECTION | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 14, 2022 | IPG-MODAFINIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2022 | MAR-ATORVASTATIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2022 | MAR-RIZATRIPTAN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2022 | ALPHAGAN | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2022 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 14, 2022 | TASIGNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2022 | CANAURAL | Dechra Veterinary Products Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2022 | RIVA-PAROXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 14, 2022 | SERTRALINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 14, 2022 | MAR-SERTRALINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 14, 2022 | WELLBUTRIN XL | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2022 | OXYNEO | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2022 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 14, 2022 | SPIKEVAX | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2022 | CLINDAMYCIN INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2022 | SANDOZ POSACONAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2022 | APO-GLICLAZIDE MR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2022 | TARO-CAPECITABINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 13, 2022 | MYCOPHENOLATE MOFETIL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 13, 2022 | CARNITOR | Leadiant Biosciences, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2022 | PMS-DICLOFENAC | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2022 | NUVARING | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 13, 2022 | PEMETREXED DISODIUM FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2022 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2022 | TRUSOPT; TRUSOPT PRESERVATIVE-FREE | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2022 | PRO-FLUCONAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 12, 2022 | TD ADSORBED | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 12, 2022 | CARBOPLATIN INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 12, 2022 | SANDOZ ATORVASTATIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 12, 2022 | JAMP DOXYCYCLINE CAPSULES | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| July 11, 2022 | WELIREG | Merck Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| July 11, 2022 | VALCYTE | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Admin |
| July 11, 2022 | ZYBAN | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 11, 2022 | RIVA-ALENDRONATE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 8, 2022 | COMBIGAN | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2022 | FRAXIPARINE; FRAXIPARINE FORTE | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2022 | VAXNEUVANCE | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 8, 2022 | RIVA-ANASTROZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 8, 2022 | MEROPENEM FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2022 | CARVEDILOL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 8, 2022 | ROCURONIUM BROMIDE INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2022 | PANTOPRAZOLE FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2022 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2022 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2022 | PEMETREXED DISODIUM FOR INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2022 | IRINOTECAN HYDROCHLORIDE INJECTION | Eugia Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| July 8, 2022 | APO-ALLOPURINOL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| July 8, 2022 | DEPAKENE | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| July 8, 2022 | SANDOZ LEVETIRACETAM | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2022 | XANAX; XANAX TS | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2022 | TISSEEL | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2022 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2022 | ALLERGY RELIEF LIQUID GELS | Juno Otc Inc | Abbreviated New Drug Submission (ANDS) · Other |
| July 7, 2022 | HYZAAR; HYZAAR DS | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2022 | COZAAR | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2022 | TEVA-LEVETIRACETAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2022 | COATED DAILY LOW DOSE ASA 81 MG | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 7, 2022 | BL LATANOPROST | Bausch & Lomb Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 7, 2022 | MARVELON 21; MARVELON 28 | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2022 | ONDANSETRON ODT | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2022 | LAPELGA | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2022 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2022 | RIVA-CLARITHROMYCIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 6, 2022 | MIRTAZAPINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| July 6, 2022 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 6, 2022 | TEVA-MYCOPHENOLATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2022 | SANDOZ FENOFIBRATE E | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2022 | ACH-DIMETHYL FUMARATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2022 | MIDAZOLAM INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2022 | SANDOZ TACROLIMUS XR | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| July 6, 2022 | TEVA-CETIRIZINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| July 6, 2022 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 6, 2022 | SANDOZ EVEROLIMUS | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 5, 2022 | SUBLOCADE | Indivior Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2022 | KUVAN | Biomarin International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2022 | CONTRAVE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2022 | CLOTRIMADERM TOPICAL; CLOTRIMADERM TOPICAL SOLUTION 1% USP | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2022 | ACTONEL; ACTONEL DR | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| July 5, 2022 | AURO-LEVETIRACETAM | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2022 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2022 | TRANEXAMIC ACID TABLETS | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 5, 2022 | MINT-ONDANSETRON | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2022 | EVKEEZA | Ultragenyx Pharmaceutical Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| July 4, 2022 | TEVA-DILTIAZEM XC | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2022 | ACCEL-ONDANSETRON | Accel Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2022 | ACH-MYCOPHENOLATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| July 4, 2022 | EPIVAL | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2022 | MS CONTIN | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| July 4, 2022 | JAMP CEPHALEXIN SUSPENSION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2022 | WEGOVY | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2022 | SANDOZ PAZOPANIB | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2022 | PIQRAY | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2022 | FLUCONAZOLE INJECTION SDZ | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 30, 2022 | JAMP DOXYCYCLINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 30, 2022 | UVADEX | Therakos Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 30, 2022 | OCTAPLASMA | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | MAR-RANITIDINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2022 | OLMESARTAN | Jubilant Generics Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2022 | GLN-ATOVAQUONE | Glenmark Pharmaceuticals Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 29, 2022 | IMBRUVICA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | RYDAPT | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | BREVICON 0.5/35 TABLETS (21-DAY PACK); BREVICON 0.5/35 TABLETS (28-DAY PACK); BREVICON 1/35 TABLETS (21-DAY PACK); BREVICON 1/35 TABLETS (28-DAY PACK) | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | RHO-NITRO PUMPSPRAY | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | ZEPZELCA | Jazz Pharmaceuticals Ireland Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | CIBINQO | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 29, 2022 | SANDOZ ONDANSETRON | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2022 | OLUMIANT | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 29, 2022 | MINT-CAPECITABINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2022 | ACH-LEVETIRACETAM | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 29, 2022 | LORATADINE SOFT GELATIN CAPSULES | Catalent Ontario Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2022 | NORITATE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2022 | RBX-ATORVASTATIN | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2022 | ATORVASTATIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 28, 2022 | JAMP PERINDOPRIL ERBUMINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2022 | RISEDRONATE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2022 | JAMP ALENDRONATE/VITAMIN D3 | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2022 | PMS-RIZATRIPTAN RDT | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2022 | OLMETEC | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2022 | OLMETEC PLUS | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2022 | SPRAVATO | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 28, 2022 | PMSC-ESOMEPRAZOLE DR | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 28, 2022 | APO-FLUTICASONE HFA | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 28, 2022 | RIVA-SERTRALINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 28, 2022 | APO-FLUOXETINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 27, 2022 | ILUMYA | Sun Pharmaceutical Industries Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2022 | ORENCIA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2022 | TEVA-ROSUVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2022 | CYTOGAM | Ki Biopharma Llc | New Drug Submission (NDS) · Admin |
| June 27, 2022 | WINRHO SDF | Ki Biopharma Llc | New Drug Submission (NDS) · Admin |
| June 27, 2022 | MAR-TRANEXAMIC ACID | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2022 | SEVOFLURANE | Piramal Critical Care, Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 27, 2022 | TOPAMAX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 27, 2022 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 24, 2022 | DORZOLAMIDE | Micro Labs Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 24, 2022 | PMS-ONDANSETRON | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2022 | TEVA-PAROXETINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 24, 2022 | AURO-PAROXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2022 | DORZOLAMIDE-TIMOLOL | Micro Labs Limited | Abbreviated New Drug Submission (ANDS) · Other |
| June 23, 2022 | ACT FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2022 | VARIZIG | Ki Biopharma Llc | New Drug Submission (NDS) · Admin |
| June 23, 2022 | RITALIN; RITALIN SR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2022 | MIFEGYMISO | Linepharma International Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2022 | TARO-FLUCONAZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 23, 2022 | CLOPIXOL ACUPHASE; CLOPIXOL DEPOT | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2022 | SUMATRIPTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 23, 2022 | TARO-CLINDAMYCIN | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 23, 2022 | PHEBURANE | Medunik Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 23, 2022 | CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2022 | PROLEUKIN | Sterimax Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2022 | ALPHAGAN P | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2022 | SCEMBLIX | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 22, 2022 | REDDY-ABIRATERONE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 22, 2022 | DUOBRII | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 22, 2022 | PMS-DEFERASIROX (TYPE J) | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 21, 2022 | CANDESARTAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2022 | ARIPIPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 21, 2022 | ACETYLCYSTEINE SOLUTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 21, 2022 | AVSOLA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2022 | TEVA-CANDESARTAN/HCTZ | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2022 | VIDAZA | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 21, 2022 | MINT-ONDANSETRON ODT | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2022 | TEVA-ABIRATERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2022 | APO-BIMATOPROST | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2022 | APO-MYCOPHENOLATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 21, 2022 | TRI-SOLFEN | Dechra Ltd | New Drug Submission (NDS) · Other |
| June 20, 2022 | CAPECITABINE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2022 | CLOTRIMADERM EXTERNAL CREAM; CLOTRIMADERM VAGINAL 3; CLOTRIMADERM VAGINAL 6 | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2022 | CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM; CLOTRIMAZOLE EXTERNAL CREAM; CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM; CLOTRIMAZOLE VAGINAL 3; CLOTRIMAZOLE VAGINAL 6 | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2022 | BELKYRA | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2022 | CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2022 | APO-IBUPROFEN; APO-IBUPROFEN CAPLET | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2022 | PRIVA-EZETIMIBE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2022 | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2022 | JAMP CLONIDINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 20, 2022 | DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION | Bausch & Lomb Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2022 | TEVA-DILTIAZEM | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 20, 2022 | APO-APIXABAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 20, 2022 | ACETYLCYSTEINE INJECTION | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 20, 2022 | APO-APIXABAN | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 17, 2022 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2022 | RIVA-ARIPIPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 17, 2022 | PRIVA-TADALAFIL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 17, 2022 | ZOPICLONE TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 17, 2022 | SANDOZ FELODIPINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 17, 2022 | JAMP PIRFENIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 17, 2022 | TEVA-NAPROXEN SODIUM; TEVA-NAPROXEN SODIUM DS | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2022 | NAT-ANASTROZOLE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 17, 2022 | CARDIZEM CD | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 17, 2022 | TARO-FUSIDIC ACID | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| June 16, 2022 | ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION; ONDANSETRON INJECTION USP; SANDOZ ONDANSETRON | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 16, 2022 | ALENDRONATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2022 | ASA | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 16, 2022 | EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2022 | CABENUVA; VOCABRIA | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 15, 2022 | ENHERTU | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| June 15, 2022 | GEMCITABINE FOR INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 15, 2022 | DECTOMAX | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2022 | TD ADSORBED | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2022 | LETYBO | Croma Aesthetics Canada, Ltd. | New Drug Submission (NDS) · Other |
| June 14, 2022 | PDP-AMANTADINE HYDROCHLORIDE CAPSULES; PDP-AMANTADINE HYDROCHLORIDE SYRUP | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 14, 2022 | REDDY-ATORVASTATIN | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 13, 2022 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2022 | ENALAPRIL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 13, 2022 | ULTRA TECHNEKOW V4 | Curium Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 13, 2022 | PRIVA-SILDENAFIL | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 13, 2022 | JAMP DILTIAZEM CD | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| June 13, 2022 | MYLAN-VERAPAMIL SR | Mylan Pharmaceuticals Ulc | New Drug Submission (NDS) · Admin |
| June 13, 2022 | IMOVANE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2022 | SOFRACORT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2022 | ISENTRESS; ISENTRESS HD | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2022 | LEMTRADA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2022 | HYDREA | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2022 | SANDOZ VORICONAZOLE; VORICONAZOLE FOR INJECTION | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2022 | TEVA-ABIRATERONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2022 | PLAQUENIL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2022 | RIVA-AMLODIPINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 10, 2022 | DIAZEPAM INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 10, 2022 | ANASTROZOLE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 10, 2022 | SANDOZ CLARITHROMYCIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2022 | PMS-DIMETHYL FUMARATE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2022 | TEVA-FENTANYL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 10, 2022 | ALBRIOZA | Amylyx Pharmaceuticals Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 10, 2022 | CRESTOR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 10, 2022 | APTIVUS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2022 | CUTAQUIG | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2022 | RIVA-PANTOPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 9, 2022 | M-QUETIAPINE FUMARATE XR | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 9, 2022 | NITISINONE TABLETS | Cycle Pharmaceuticals Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2022 | TEVA-DULOXETINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2022 | TRAMACET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2022 | MAEVE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2022 | JAMP LATANOPROST | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| June 9, 2022 | PROPAFENONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 9, 2022 | BIO-FINASTERIDE | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| June 9, 2022 | TEVA-TAMOXIFEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2022 | MED-CLINDAMYCIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 9, 2022 | CYRAMZA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2022 | NEXGARD | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 9, 2022 | BOVICAM 20 | Modern Veterinary Therapeutics Llc | Abbreviated New Drug Submission (ANDS) · Other |
| June 8, 2022 | AZACITIDINE FOR INJECTION | Hikma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2022 | ENTYVIO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2022 | VOLTAREN; VOLTAREN SR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2022 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 8, 2022 | LITHANE | Erfa Canada 2012 Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 8, 2022 | AURO-SERTRALINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2022 | LYRICA | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2022 | SANDOZ DICLOFENAC; SANDOZ DICLOFENAC SR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2022 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2022 | SUFENTANIL CITRATE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 7, 2022 | LEFLUNOMIDE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 7, 2022 | APO-CARBAMAZEPINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2022 | TOPIRAMATE TABLETS USP | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 7, 2022 | TEVA-DICLOFENAC EC; TEVA-DICLOFENAC SR | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| June 7, 2022 | KIMMTRAK | Immunocore Ireland Limited | New Drug Submission (NDS) · Priority-NAS |
| June 7, 2022 | APO-CARBAMAZEPINE CR | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 6, 2022 | NAT-QUETIAPINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 6, 2022 | INVANZ | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2022 | KYMRIAH | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2022 | ZOLGENSMA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2022 | ZEJULA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| June 6, 2022 | REDDY-DASATINIB | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2022 | TEVA-CLINDAMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2022 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2022 | SANDOZ DULOXETINE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 3, 2022 | APO-BUSPIRONE | Apotex Inc. | New Drug Submission (NDS) · Labelling Only |
| June 3, 2022 | CLEVIPREX | Chiesi Farmaceutici S.P.A. | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2022 | OPDIVO | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2022 | TRANEXAMIC ACID INJECTION BP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2022 | PRIVA-SERTRALINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 2, 2022 | PANTOPRAZOLE TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 2, 2022 | ESCITALOPRAM TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 2, 2022 | AG-RISPERIDONE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 2, 2022 | APO-METHOTREXATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2022 | POTELIGEO | Kyowa Kirin, Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 2, 2022 | TOPICORT | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2022 | ORLADEYO | Biocryst Pharmaceuticals Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| June 2, 2022 | AURO-DEFERASIROX (TYPE J) | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| June 2, 2022 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2022 | ELAVIL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 2, 2022 | SANDOZ AMIODARONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2022 | RAN-CLARITHROMYCIN; TARO-CLARITHROMYCIN; TARO-CLARITHROMYCIN XL | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 2, 2022 | MONTELUKAST | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| June 2, 2022 | SANDOZ QUETIAPINE XRT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 2, 2022 | DOBUTAMINE INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2022 | QUETIAPINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2022 | NRA-PERINDOPRIL | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| June 1, 2022 | BUSPIRONE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| June 1, 2022 | PRIVA-DULOXETINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2022 | SPIKEVAX | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2022 | ERLEADA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2022 | FLUVOXAMINE TABLETS | Ivax Pharmaceuticals Incorporated | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| June 1, 2022 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2022 | ATARAX SYRUP 2MG/ML | Erfa Canada 2012 Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| June 1, 2022 | METFORMIN TABLETS | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| June 1, 2022 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2022 | CHOLETEC | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2022 | REDESCA / REDESCA HP | Shenzhen Techdow Pharmaceutical Co., Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2022 | VELTASSA | Vifor Fresenius Medical Care Renal Pharma Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2022 | PRIVA-PERINDOPRIL ERBUMINE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 31, 2022 | CIALIS | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2022 | AURO-CANDESARTAN HCT | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2022 | TEVA-ALENDRONATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 31, 2022 | EMLA CREAM | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 31, 2022 | XPOVIO | Forus Therapeutics Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 31, 2022 | PMS-METHOTREXATE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2022 | PMS-FLUCONAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 30, 2022 | TEVA-FLUCONAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 30, 2022 | NYDA | G. Pohl-Boskamp GmbH & Co. KG | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2022 | LOVENOX HP | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 30, 2022 | TEVA-SERTRALINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2022 | VABYSMO | Hoffmann-La Roche Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 27, 2022 | VENLAFAXINE XR | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 27, 2022 | JORVEZA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2022 | CLINDAMYCIN INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| May 27, 2022 | OLANZAPINE; OLANZAPINE ODT | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2022 | DULOXETINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2022 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2022 | MAR-DIMETHYL FUMARATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 27, 2022 | AURO-FLUOXETINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2022 | TABRECTA | Novartis Pharmaceuticals Canada Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 26, 2022 | AG-DORZOLAMIDE TIMOLOL | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 26, 2022 | SANDOZ ABIRATERONE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2022 | SANDOZ REPAGLINIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2022 | JAMP-RISPERIDONE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 26, 2022 | PMS-RABEPRAZOLE EC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2022 | GLN-DIMETHYL FUMARATE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2022 | MINT-PREGABALIN | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 26, 2022 | APO-METFORMIN ER | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2022 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2022 | SANDOZ DIMETHYL FUMARATE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2022 | OXPAM | Biomed Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2022 | CEFEPIME FOR INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 25, 2022 | FENTANYL CITRATE INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 25, 2022 | LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 25, 2022 | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 25, 2022 | MINT-ATENOL | Mint Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 25, 2022 | PMS-PAROXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 25, 2022 | ALLERGY RELIEF; EXTRA STRENGTH ALLERGY RELIEF | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2022 | OMVYENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 24, 2022 | NAT-BENDAMUSTINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2022 | MAR-DARUNAVIR | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2022 | DORZOLAMIDE EYE DROPS BP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2022 | DORZOLAMIDE AND TIMOLOL EYE DROPS BP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 24, 2022 | COSOPT; COSOPT PRESERVATIVE-FREE | Elvium Life Sciences | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2022 | BOTOX, BOTOX COSMETIC | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2022 | PMS-METOCLOPRAMIDE ORAL SOLUTION; PMS-METOCLOPRAMIDE TABLETS | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2022 | AURO-DARUNAVIR | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2022 | AURO-TOPIRAMATE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 24, 2022 | PROHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2022 | RESTASIS | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 24, 2022 | AURO-ABACAVIR/LAMIVUDINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 20, 2022 | LORBRENA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2022 | TEVA-ESOMEPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 20, 2022 | GLEEVEC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2022 | PMS-LEVETIRACETAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 20, 2022 | HEPSERA | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2022 | CELESTONE SOLUSPAN | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 20, 2022 | FUROSEMIDE INJECTION USP | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 20, 2022 | FUROSEMIDE SPECIAL INJECTION | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 20, 2022 | BACITRACIN MD | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 19, 2022 | GONAL-F PEN | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2022 | OCTAGAM 10% | Octapharma Pharmazeutika Produktionsges M B H | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2022 | LATANOPROST OPHTHALMIC SOLUTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 19, 2022 | DUODOPA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2022 | IRINOTECAN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| May 19, 2022 | RYBELSUS | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2022 | ZONOVATE | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2022 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2022 | NRA-CIPROFLOXACIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 19, 2022 | BACLOFEN INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 19, 2022 | NALOXONE INJECTABLE | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 19, 2022 | SIMPLICEF | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 19, 2022 | LUMIFY | Bausch & Lomb Inc. | New Drug Submission (NDS) · Other |
| May 18, 2022 | NIMENRIX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2022 | THIOTEPA FOR INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 18, 2022 | XATRAL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2022 | LOSEC MUPS | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2022 | IPG-PAROXETINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 18, 2022 | LOSEC | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2022 | LOSEC | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2022 | TIBELLA | BioSyent Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 18, 2022 | DYMISTA | BGP Pharma ULC | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2022 | ACTIVASE RT-PA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2022 | AVSOLA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2022 | ALPROLIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2022 | ENSTILAR | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2022 | TRISPAN | Medexus Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 17, 2022 | APO-RIZATRIPTAN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 17, 2022 | ONDANSETRON INJECTION, USP | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 17, 2022 | PMS-ANASTROZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | QUETIAPINE XR | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2022 | DEFERASIROX (TYPE J) | Jubilant Generics Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | SPIKEVAX | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2022 | AMLODIPINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2022 | DIGOXIN INJECTION C.S.D. | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2022 | NAT-TERIFLUNOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | NALOXONE HYDROCHLORIDE INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2022 | AG-LETROZOLE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2022 | PERINDOPRIL ERBUMINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2022 | CARVEDILOL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 16, 2022 | PRIVA-CELECOXIB | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2022 | JAMP-LETROZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| May 16, 2022 | CANDESARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 16, 2022 | AURO-TERIFLUNOMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 16, 2022 | PMS-TERIFLUNOMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | NAT-TERIFLUNOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | M-TERIFLUNOMIDE | Mantra Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | TEVA-TERIFLUNOMIDE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | PMS-TERIFLUNOMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | NAT-TERIFLUNOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | PMS-TERIFLUNOMIDE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | APO-TERIFLUNOMIDE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | AURO-TERIFLUNOMIDE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | JAMP TERIFLUNOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | APO-TERIFLUNOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | ACH-TERIFLUNOMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | MAR-TERIFLUNOMIDE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | AURO-TERIFLUNOMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | APO-TERIFLUNOMIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | LEVETIRACETAM INJECTION USP | Sterimax Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | PMS-TERIFLUNOMIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | M-TERIFLUNOMIDE | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | SANDOZ TERIFLUNOMIDE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | ACH-TERIFLUNOMIDE | Accord Healthcare Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | JAMP TERIFLUNOMIDE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | TEVA-TERIFLUNOMIDE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | MAR-TERIFLUNOMIDE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 16, 2022 | JAMP TERIFLUNOMIDE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 16, 2022 | NAT-TERIFLUNOMIDE | Natco Pharma (Canada) Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 13, 2022 | IPG-ALLOPURINOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2022 | IMODIUM COMPLETE | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2022 | SANDOZ IRBESARTAN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2022 | PMS-CLARITHROMYCIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2022 | PMS-PANTOPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2022 | AG-ACET-TRAMADOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 13, 2022 | APO-VERAP | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 13, 2022 | HYDROXYZINE HYDROCHLORIDE INJECTION USP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2022 | ERTAPENEM FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2022 | ESOMEPRAZOLE | Ethypharm Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2022 | MED-VORICONAZOLE | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2022 | DEPO-MEDROL WITH LIDOCAINE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 12, 2022 | ACH-LACOSAMIDE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 12, 2022 | SANDOZ QUETIAPINE XR | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2022 | JANSSEN COVID-19 VACCINE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2022 | RIVA-FLUOXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 11, 2022 | BAMBEVI | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2022 | TEPADINA | Adienne Sa | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2022 | ALECENSARO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2022 | GAZYVA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 11, 2022 | PMS-SUMATRIPTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 11, 2022 | REDDY-LENALIDOMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2022 | AG-ATENOLOL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2022 | AG-ATENOLOL | Angita Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 10, 2022 | QUETIAPINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2022 | JAMP-ATENOLOL | JAMP Pharma Corporation | Supplement to a New Drug Submission (SNDS) · Admin |
| May 10, 2022 | FLAGYL | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2022 | FLAGYSTATIN | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2022 | QINLOCK | Deciphera Pharmaceuticals. Llc | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2022 | KETOPROFEN; KETOPROFEN SR; KETOPROFEN-E | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2022 | JAMP-ATENOLOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 10, 2022 | ADRIAMYCIN PFS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2022 | NABUMETONE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2022 | VORICONAZOLE FOR INJECTION | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 10, 2022 | CEFTAZIDIME FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 10, 2022 | SIMPARICA TRIO | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 10, 2022 | AG-PERINDOPRIL ERBUMINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 9, 2022 | PREVNAR 20 | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 9, 2022 | ROZLYTREK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2022 | CLOBEX SHAMPOO; CLOBEX SPRAY | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2022 | ZOCOR | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 9, 2022 | PMS-SERTRALINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 9, 2022 | TEVA-ONDANSETRON | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| May 9, 2022 | XELJANZ; XELJANZ XR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2022 | ENTECAVIR | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 6, 2022 | TIGECYCLINE FOR INJECTION | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 6, 2022 | RIVA-CIPROFLOXACIN | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 6, 2022 | JAMP-CIPROFLOXACIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 6, 2022 | BREYANZI | Celgene Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| May 6, 2022 | SEPTRA INJECTION; SEPTRA PEDIATRIC SUSPENSION | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 6, 2022 | AG-CIPROFLOXACIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 6, 2022 | BUTORPHANOL NASAL SPRAY | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 6, 2022 | IBUPROFEN CAPLETS 200 MG; IBUPROFEN TABLETS 200 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2022 | PRIMAQUINE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2022 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2022 | ATGAM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2022 | NOROMBY; NOROMBY HP | Juno Pharmaceuticals Corp. | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2022 | LENVIMA | Eisai Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2022 | VORICONAZOLE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 5, 2022 | MAR-RISPERIDONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 5, 2022 | VAXZEVRIA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 5, 2022 | AURO-AMBRISENTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 4, 2022 | DRAXIMAGE MDP; DRAXIMAGE MDP-25 | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2022 | SANDOZ DILTIAZEM T | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2022 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2022 | HEMLIBRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2022 | PEMETREXED FOR INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 4, 2022 | MYLAN-DIVALPROEX | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2022 | ESAMUZE | Dr Reddys Laboratories Ltd | New Drug Submission (NDS) · Other |
| May 4, 2022 | CLOZARIL | Hls Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| May 4, 2022 | APO-DORZO-TIMOP | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2022 | AZITHROMYCIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| May 3, 2022 | SANDOZ DICLOFENAC RAPIDE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| May 3, 2022 | CABLIVI | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 3, 2022 | TELMISARTAN HCTZ | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 3, 2022 | IPG-SERTRALINE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2022 | TEVA-ABACAVIR/LAMIVUDINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 3, 2022 | NRA-CANDESARTAN | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| May 2, 2022 | PMS-LURASIDONE | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| May 2, 2022 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| May 2, 2022 | VALSARTAN | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| May 2, 2022 | MARCAINE E | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2022 | TACTUPUMP FORTE; TACTUPUMP | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2022 | DIFFERIN; DIFFERIN XP | Galderma Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2022 | GENTAMICIN INJECTION USP | Hikma Canada Limited | New Drug Submission (NDS) · Admin |
| May 2, 2022 | FULVESTRANT INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2022 | ZADITEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| May 2, 2022 | TARO-SUMATRIPTAN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2022 | MINT-TRAMADOL/ACET | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2022 | LORAZEPAM SUBLINGUAL | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| May 2, 2022 | TARO-LURASIDONE | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 2, 2022 | EPRECIS | Ceva Animal Health Inc | Abbreviated New Drug Submission (ANDS) · Other |
| May 2, 2022 | JAMP LURASIDONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 29, 2022 | DUOKOPT | Laboratoires Théa | Abbreviated New Drug Submission (ANDS) · Other |
| April 29, 2022 | JUXTAPID | Amryt Pharmaceuticals Dac | New Drug Submission (NDS) · Admin |
| April 29, 2022 | AVASTIN | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2022 | LOSARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 29, 2022 | PRO-DESVENLAFAXINE | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| April 29, 2022 | FUROSEMIDE INJECTION USP | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 29, 2022 | NRA-TRAMADOL/ACET | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2022 | DERMATOP EMOLLIENT CREAM; DERMATOP OINTMENT | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2022 | APO-TOPIRAMATE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2022 | APO-RAMIPRIL/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 29, 2022 | ADACEL-POLIO | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2022 | RIVOTRIL | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Other |
| April 29, 2022 | JAMP-ROSUVASTATIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 29, 2022 | EVRA | Searchlight Pharma Inc. | New Drug Submission (NDS) · Admin |
| April 29, 2022 | METOPROLOL | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 29, 2022 | GASTROGRAFIN | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2022 | PRIVA-FLUCONAZOLE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 28, 2022 | PEDIAPRED | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2022 | TEVA-SIMVASTATIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2022 | CABOMETYX | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| April 28, 2022 | CAPRELSA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 28, 2022 | PMS-IRBESARTAN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2022 | PMS-ABACAVIR-LAMIVUDINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2022 | TEVA-COMBO STERINEBS | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 28, 2022 | APO-OMEPRAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2022 | IMURAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2022 | MINT-ALENDRONATE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2022 | APO-RILUZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2022 | TEVA-FINGOLIMOD | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 27, 2022 | ENSTILAR | Leo Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 27, 2022 | GD-AMLODIPINE/ATORVASTATIN | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| April 27, 2022 | APO-ATORVASTATIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 26, 2022 | AMIODARONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 26, 2022 | OLMESARTAN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 26, 2022 | SANDOZ AMBRISENTAN TABLETS | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 25, 2022 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2022 | CAFFEINE CITRATE INJECTION USP | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 25, 2022 | SPIRIVA | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2022 | CAFFEINE CITRATE ORAL SOLUTION USP | Omega Laboratories Limited | Abbreviated New Drug Submission (ANDS) · Other |
| April 25, 2022 | VERZENIO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 25, 2022 | PMS-ARIPIPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 24, 2022 | PMS-CLOPIDOGREL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2022 | JAMP TOPIRAMATE TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2022 | AG-ROSUVASTATIN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 22, 2022 | ACH-FLUOXETINE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 22, 2022 | PLEGRIDY | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2022 | VIMOVO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2022 | VEKLURY | Gilead Sciences Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 22, 2022 | VRAYLAR | Allergan Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 22, 2022 | DAPTOMYCIN FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 21, 2022 | RIVA-ARIPIPRAZOLE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 21, 2022 | JAMP-ONDANSETRON | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 21, 2022 | PRO-FLUOXETINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 21, 2022 | EMLA CREAM; EMLA PATCH | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | REPATHA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | PENTHROX | Endo Ventures Ltd | New Drug Submission (NDS) · Admin |
| April 21, 2022 | EPREX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | MICARDIS PLUS | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | UPTRAVI | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | TEVA-FLUOXETINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | VASCEPA | Hls Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 21, 2022 | SUPRELORIN 4.7 MG IMPLANT | Virbac Animal Health Inc | New Drug Submission (NDS) · Other |
| April 20, 2022 | LUXTURNA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 20, 2022 | TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| April 19, 2022 | SUPEMTEK | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2022 | TEVA-ESOMEPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 19, 2022 | RETEVMO | Loxo Oncology Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 19, 2022 | PAQ FLOR | Phibro Animal Health Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 14, 2022 | NAT-ONDANSETRON | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2022 | PMS-ESCITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2022 | PAXLOVID | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2022 | TAVNEOS | Vifor Fresenius Medical Care Renal Pharma Ltd | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 14, 2022 | AMIKACIN SULFATE INJECTION | Hikma Canada Limited | Abbreviated New Drug Submission (ANDS) · Admin |
| April 14, 2022 | LOSARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 14, 2022 | EVUSHELD | Astrazeneca Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| April 14, 2022 | TORADOL IM | Atnahs Pharma Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 14, 2022 | KETOROLAC TROMETHAMINE INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 14, 2022 | JAMP TAMSULOSIN | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| April 13, 2022 | HAEGARDA | Csl Behring Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2022 | CRESEMBA | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2022 | AG-CLOPIDOGREL | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 13, 2022 | AG-QUETIAPINE | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 13, 2022 | APIDRA | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2022 | DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2022 | IRBESARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 13, 2022 | GLYBURIDE | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| April 13, 2022 | FLUCONAZOLE 150 | Taro Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Admin |
| April 13, 2022 | CEFOTAXIME SODIUM FOR INJECTION, BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2022 | NAPROXEN - 250; NAPROXEN - 375; NAPROXEN - 500 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2022 | TREMFYA; TREMFYA ONE-PRESS | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 13, 2022 | PRO-OXAZEPAM | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| April 13, 2022 | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 13, 2022 | SENSORCAINE; SENSORCAINE WITH EPINEPHRINE | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 12, 2022 | RIVA-CYPROTERONE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 12, 2022 | MYLAN-PROPAFENONE | Mylan Pharmaceuticals Ulc | Supplement to a New Drug Submission (SNDS) · Admin |
| April 12, 2022 | JAMP-QUETIAPINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 12, 2022 | TRANDOLAPRIL | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| April 12, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| April 12, 2022 | TEVA-LISINOPRIL (TYPE P) | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 12, 2022 | CIPROFLOXACIN INTRAVENOUS INFUSION BP; SANDOZ CIPROFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2022 | PROLOPA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2022 | APO-FLUTICASONE HFA | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2022 | VENCLEXTA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 11, 2022 | MINT-FUROSEMIDE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 11, 2022 | PMS-FINGOLIMOD | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2022 | BRAFTOVI | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2022 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2022 | SEMGLEE | BGP Pharma ULC | New Drug Submission (NDS) · Other |
| April 8, 2022 | FLULAVAL TETRA | Id Biomedical Corporation Of Quebec | Supplement to a New Drug Submission (SNDS) · Other |
| April 8, 2022 | AMLODIPINE TABLETS | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 8, 2022 | EZETIMIBE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 8, 2022 | PRAXIS ASA EC 81 MG DAILY LOW DOSE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 8, 2022 | ASA 81 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2022 | RANITIDINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 8, 2022 | PRZ-OLMESARTAN/HCTZ | Pharmaris Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 8, 2022 | ZEPOSIA | Celgene Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2022 | PERJETA; PERJETA-HERCEPTIN COMBO PACK | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Priority |
| April 7, 2022 | MAVIRET | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2022 | QUETIAPINE FUMARATE XR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 7, 2022 | IMOVANE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2022 | DUODOPA | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2022 | AURO-BOSENTAN | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| April 7, 2022 | LAMOTRIGINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 7, 2022 | PRECEDEX | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 7, 2022 | PRIVA-DUTASTERIDE | Nora Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| April 7, 2022 | ONDANSETRON INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2022 | TRANDOLAPRIL | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2022 | TORADOL | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2022 | NRA-QUETIAPINE XR | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2022 | CANDESARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2022 | OXYBUTYNIN | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| April 6, 2022 | GLEEVEC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2022 | JARDIANCE | Boehringer Ingelheim (Canada) Ltd. | Supplement to a New Drug Submission (SNDS) · Priority |
| April 6, 2022 | GARDASIL9 | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2022 | CANDESARTAN-HCTZ | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| April 6, 2022 | CARBOPLATIN INJECTION BP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 6, 2022 | TEVA-CLOBAZAM | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 6, 2022 | SANDOZ AMPHETAMINE XR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2022 | REMSIMA SC | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 5, 2022 | AMIODARONE HYDROCHLORIDE FOR INJECTION | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2022 | ACH-ANASTROZOLE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2022 | TEVA-ANASTROZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2022 | PMS-ANAGRELIDE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2022 | ACT ENALAPRIL | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2022 | PMS-CARVEDILOL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 5, 2022 | APO-METHIMAZOLE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 4, 2022 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2022 | IMVAMUNE | Bavarian Nordic As | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2022 | INFLECTRA | Celltrion Healthcare Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| April 4, 2022 | NAT-ZOLMITRIPTAN | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 4, 2022 | MINT-RANITIDINE | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| April 1, 2022 | TEVA-TOPIRAMATE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2022 | PROPOFOL INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2022 | PMS-ATORVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2022 | MAR-FLUCONAZOLE-150 | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| April 1, 2022 | TECTA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | CLINIMIX E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | CLINIMIX | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | PANTOLOC | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | CLINIMIX E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | CLINIMIX | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | CLINIMIX E | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | DILANTIN INFATABS; DILANTIN-125 SUSPENSION; DILANTIN-30 SUSPENSION | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| April 1, 2022 | BUPAQ | Richter Pharma Ag | Abbreviated New Drug Submission (ANDS) · Other |
| March 31, 2022 | NAT-ABIRATERONE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | LINEZOLID INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | MAR-ENALAPRIL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | BIJUVA | Knight Therapeutics Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | DILANTIN | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | SANDOZ LURASIDONE | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 31, 2022 | ASA DAILY LOW DOSE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 31, 2022 | ACH-ALENDRONATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | COLD + SINUS PLUS | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | APO-DICLO | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | TARO-TRAMADOL ER | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | SANDOZ TRAMADOL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | PMS-TRAMADOL-ACET | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | CREDELIO CAT | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| March 31, 2022 | TEVA-TRAMADOL/ACETAMINOPHEN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | TARO-TRAMADOL/ACET | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | MAR-TRAMADOL/ACET | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | MAR-TRAMADOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | JAMP-ACET-TRAMADOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | JAMP TRAMADOL HCL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | JAMP TRAMADOL | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | IPG-TRAMADOL/ACET | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | AURO-TRAMADOL/ACETAMINOPHEN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | AURO-TRAMADOL | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | APO-TRAMADOL/ACET | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | APO-TRAMADOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 31, 2022 | ZYTRAM XL | Purdue Pharma | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | ULTRAM | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | TRIDURAL | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | TRAMACET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | RALIVIA | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | DURELA | Cipher Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 31, 2022 | BEXSERO | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2022 | ALEMBIC-TELMISARTAN/HCTZ | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2022 | TAKHZYRO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2022 | RYBREVANT | Janssen Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 30, 2022 | PALYNZIQ | Biomarin International Limited | New Drug Submission (NDS) · New Active Substance (NAS) |
| March 30, 2022 | QINLOCK | Deciphera Pharmaceuticals. Llc | Supplement to a New Drug Submission (SNDS) · Other |
| March 30, 2022 | DESMOPRESSIN SPRAY | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2022 | SANDOZ LISINOPRIL HCT | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 30, 2022 | SANDOZ PIRFENIDONE TABLETS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 29, 2022 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2022 | TOPIRAMATE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 29, 2022 | SERTRALINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 29, 2022 | PROLIA | Amgen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 29, 2022 | PMS-ALENDRONATE; PMS-ALENDRONATE-FC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2022 | PMS-CANDESARTAN-HCTZ | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2022 | ACT CIPROFLOXACIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2022 | PORTIA 21; PORTIA 28 | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2022 | ACETAMINOPHEN INJECTION | Baxter Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 28, 2022 | MARQUIS | Boehringer Ingelheim Animal Health Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2022 | OVIDREL | Emd Serono A Division Of Emd Inc Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2022 | QUETIAPINE TABLETS | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2022 | DYSPORT AESTHETIC; DYSPORT THERAPEUTIC | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2022 | FOSRENOL | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2022 | APO-NITRAZEPAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2022 | TARO-TICAGRELOR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2022 | PENTASA | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2022 | CYRAMZA | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2022 | ULTRAVIST 300; ULTRAVIST 370 | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 25, 2022 | PMS-ENTECAVIR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2022 | MED-MOXIFLOXACIN | Generic Medical Partners Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 25, 2022 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2022 | RIVAROXABAN | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 24, 2022 | MINT-CLOPIDOGREL | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Admin |
| March 24, 2022 | OVADINE | Syndel Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2022 | PHARMA-LEVETIRACETAM | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 24, 2022 | JANSSEN COVID-19 VACCINE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2022 | DOXYCYCLINE CAPSULES; DOXYCYCLINE TABLETS | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 24, 2022 | RIVA-CITALOPRAM | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 24, 2022 | TEVA-LANSOPRAZOLE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2022 | JAKAVI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2022 | LEVOTHYROXINE SODIUM FOR INJECTION | Avir Pharma Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 24, 2022 | NASONEX | Organon Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2022 | IMPROVEST | Zoetis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 24, 2022 | ABILIFY MAINTENA | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2022 | MELPHALAN FOR INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| March 23, 2022 | AURO-LACOSAMIDE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2022 | DURATOCIN | Ferring Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2022 | INQOVI | Otsuka Pharmaceutical Co Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2022 | AA-FENO-MICRO | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 23, 2022 | TEVA-CLINDAMYCIN | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2022 | KALYDECO | Vertex Pharmaceuticals (Canada) Incorporated | Supplement to a New Drug Submission (SNDS) · Priority |
| March 23, 2022 | ASA 81 MG | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 23, 2022 | OXALIPLATIN INJECTION | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2022 | MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 23, 2022 | LIBTAYO | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Priority |
| March 23, 2022 | RHOLISTIQ | Kadmon Pharmaceuticals Llc | New Drug Submission (NDS) · Priority-NAS |
| March 22, 2022 | PRO-ALPRAZOLAM; PRO-ALPRAZOLAM TS | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| March 22, 2022 | HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 22, 2022 | PRO-LORAZEPAM | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2022 | PMS-ESOMEPRAZOLE DR | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 21, 2022 | PROPOFOL INJECTION | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 21, 2022 | AZACITIDINE FOR INJECTION | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 21, 2022 | SOLIFENACIN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2022 | JAMP-ATORVASTATIN | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 21, 2022 | CONCERTA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 19, 2022 | FLURBIPROFEN | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 18, 2022 | CANDESARTAN CILEXETIL | Alembic Pharmaceuticals Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2022 | FLUOXETINE | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 18, 2022 | APO-VARENICLINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2022 | IBUPROFEN CAPLETS 200 MG; IBUPROFEN TABLETS 200 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2022 | AURO-ARIPIPRAZOLE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 18, 2022 | SUBLINOX | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2022 | SPIKEVAX | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2022 | BRENZYS | Samsung Bioepis Co., Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 17, 2022 | TELMISARTAN HCTZ | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 17, 2022 | SANDOZ ARIPIPRAZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 17, 2022 | NRA-CLOPIDOGREL | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 16, 2022 | PMS-ROSUVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2022 | PMSC-CELECOXIB | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2022 | APO-CIPROFLOX | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 16, 2022 | SKYRIZI | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| March 16, 2022 | ZYNRELEF | Heron Therapeutics, Inc. | New Drug Submission (NDS) · Other |
| March 16, 2022 | SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 15, 2022 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2022 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2022 | PRO-LISINOPRIL - 10; PRO-LISINOPRIL - 5; PRO-LISINOPRIL- 20 | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| March 15, 2022 | IDAMYCIN PFS | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2022 | CAPECITABINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 15, 2022 | BUDESONIDE | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Admin |
| March 15, 2022 | BIO-LETROZOLE | Biomed Pharma | Abbreviated New Drug Submission (ANDS) · Admin |
| March 15, 2022 | JAMP GEFITINIB | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 15, 2022 | IBAVYR | Pendopharm Division Of Pharmascience Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 15, 2022 | XEOMIN | Merz Pharmaceuticals Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2022 | PMS-VALPROIC ACID; PMS-VALPROIC ACID E.C. | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2022 | TARO-QUETIAPINE | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2022 | CLINDA-T | Bausch Health, Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2022 | JAMP-MONTELUKAST | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2022 | OSNUVO | Avir Pharma Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2022 | SANDOZ PIRFENIDONE CAPSULES | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2022 | IMOVANE | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 14, 2022 | DESLORATADINE ALLERGY CONTROL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 14, 2022 | NRA-ZOPICLONE | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 14, 2022 | GLYBURIDE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 14, 2022 | FLUVOXAMINE-100; FLUVOXAMINE-50 | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 11, 2022 | TEVA-EVEROLIMUS | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 11, 2022 | EXTRA STRENGTH IBUPROFEN; IBUPROFEN CAPLETS; IBUPROFEN TABLETS | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 11, 2022 | CEFTRIAXONE SODIUM FOR INJECTION BP | Pfizer Canada Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 11, 2022 | DIARRHEA RELIEF | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2022 | DRAXIMAGE DTPA | Jubilant Draximage Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2022 | AMIKACIN SULFATE INJECTION | Teligent Pharma, Inc . | Abbreviated New Drug Submission (ANDS) · Other |
| March 11, 2022 | DIARRHEA RELIEF FAST DISSOLVE | Juno Otc Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 11, 2022 | IPG-RISPERIDONE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 11, 2022 | ZYMAR | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2022 | GLN-TOPIRAMATE | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 11, 2022 | KISQALI | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 11, 2022 | COMBIVIR | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2022 | ACTEMRA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2022 | CELEBREX | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 10, 2022 | AURO-CLOZAPINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2022 | NOVOLIN GE 30/70; NOVOLIN GE 50/50; NOVOLIN GE NPH; NOVOLIN GE TORONTO | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2022 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2022 | KEYTRUDA | Merck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2022 | MAR-FINGOLIMOD | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 9, 2022 | PMS-FLUOXETINE | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 9, 2022 | SANDOZ CIPROFLOXACIN | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 8, 2022 | BYOOVIZ | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| March 8, 2022 | FLUCELVAX QUAD | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 8, 2022 | JAMP VORICONAZOLE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2022 | KETAMINE INJECTION, BP | Baxter Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| March 8, 2022 | PRO-QUETIAPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2022 | SOLIFENACIN | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2022 | MINT-QUETIAPINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 7, 2022 | TARO-ESOMEPRAZOLE | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| March 7, 2022 | JUXTAPID | Aegerion Pharmaceuticals Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 7, 2022 | RIVA-CLONAZEPAM | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| March 7, 2022 | ACH-TOPIRAMATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 7, 2022 | OXLUMO | Alnylam Netherlands B.V. | New Drug Submission (NDS) · Priority-NAS |
| March 4, 2022 | AFLURIA TETRA | Seqirus Pty Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2022 | OLMESARTAN | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 4, 2022 | CAELYX | Baxter Corporation | New Drug Submission (NDS) · Admin |
| March 4, 2022 | AG-DESVENLAFAXINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 4, 2022 | TYKERB | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 4, 2022 | TARO-CARBAMAZEPINE; TARO-CARBAMAZEPINE CHEWABLE TABLETS; TARO-CARBAMAZEPINE CR | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 4, 2022 | CREDELIO PLUS | Elanco Canada Limited | New Drug Submission (NDS) · Other |
| March 4, 2022 | CITALOPRAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 4, 2022 | RIVA-METFORMIN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| March 3, 2022 | RIVA-QUETIAPINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 3, 2022 | YERVOY | Bristol-Myers Squibb Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2022 | FLUZONE HIGH-DOSE QUADRIVALENT; FLUZONE QUADRIVALENT | Sanofi Pasteur Limited | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2022 | AG-PANTOPRAZOLE SODIUM | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 3, 2022 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2022 | BYDUREON BCISE | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2022 | PMS-ANASTROZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2022 | CONTRAVE | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 3, 2022 | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 3, 2022 | PMS-PAZOPANIB | Pharmascience Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 3, 2022 | EFFEXOR XR | Upjohn Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2022 | TARO-BUPRENORPHINE/NALOXONE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2022 | PMS-FLUOXETINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2022 | TARO-ANASTROZOLE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 2, 2022 | LANSOPRAZOLE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| March 2, 2022 | ZAVESCA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2022 | TEGSEDI | Akcea Therapeutics Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2022 | PAT-GALANTAMINE ER | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 2, 2022 | ETOMIDATE INJECTION USP | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| March 2, 2022 | PRO-METFORMIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| March 1, 2022 | COSENTYX | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2022 | ACH-FINGOLIMOD | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2022 | LEVULAN KERASTICK | Dusa Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2022 | AURO-CIPROFLOXACIN | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2022 | KINEVAC | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2022 | FLUTAMIDE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| March 1, 2022 | CLONAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| March 1, 2022 | KAZANO | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2022 | CRYSVITA | Kyowa Kirin, Inc. | New Drug Submission (NDS) · Admin |
| February 28, 2022 | DULOXETINE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 28, 2022 | NESINA | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2022 | OMNIPAQUE 180; OMNIPAQUE 240; OMNIPAQUE 300; OMNIPAQUE 350 | Ge Healthcare Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2022 | ZYKADIA | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 28, 2022 | SANDOZ FINASTERIDE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 28, 2022 | VIMOVO | Xediton Pharmaceuticals Inc. | New Drug Submission (NDS) · Admin |
| February 25, 2022 | GALANTAMINE ER | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 25, 2022 | TACHOSIL | Corza Medical Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 25, 2022 | SANDOZ INDOMETHACIN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2022 | COVIFENZ | Medicago Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 24, 2022 | ADYNOVATE | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2022 | ASA 81 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2022 | ENTERIC COATED DAILY LOW DOSE ASA 81 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 24, 2022 | SANDOZ FINGOLIMOD | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2022 | LUMIGAN RC | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2022 | NETVISION | Canadian Molecular Imaging Probe Consortium (Canprobe) | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 24, 2022 | MULTIHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| February 24, 2022 | TOPAMAX | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2022 | MINT-FLUOXETINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2022 | LYSODREN | Hra Pharma Rare Diseases | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2022 | METHOTREXATE INJECTION USP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2022 | APO-DUTASTERIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2022 | LABETALOL HYDROCHLORIDE INJECTION USP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2022 | BEOVU | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2022 | TARO-FINGOLIMOD | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 23, 2022 | VYNDAQEL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 23, 2022 | MINT-TOLTERODINE | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2022 | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2022 | REDESCA | Shenzhen Techdow Pharmaceutical Co., Ltd. | Supplement to a New Drug Submission (SNDS) · Other |
| February 22, 2022 | CYCLOBENZAPRINE | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 22, 2022 | OXALIPLATIN INJECTION, USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2022 | CEPHALEXIN | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2022 | ZOLEDRONIC ACID FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 22, 2022 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 21, 2022 | LYNPARZA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 21, 2022 | CLARITHROMYCIN | Sanis Health Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 21, 2022 | ARIMIDEX | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 21, 2022 | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 21, 2022 | PAMIDRONATE DISODIUM OMEGA | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2022 | COMIRNATY | Biontech Manufacturing Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2022 | BRUKINSA | Beigene Switzerland Gmbh | Supplement to a New Drug Submission (SNDS) · Priority |
| February 18, 2022 | HYDROXYCHLOROQUINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 18, 2022 | TENOFOVIR | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 18, 2022 | MINT-ATENOL | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2022 | ATOMOXETINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 18, 2022 | VALSARTAN HCT | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 18, 2022 | CAMPTOSAR | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2022 | PENNSAID | Paladin Labs Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2022 | ARTHROTEC 50; ARTHROTEC 75 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 18, 2022 | MYLAN-TOPIRAMATE | Mylan Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 18, 2022 | CEFTAZIDIME FOR INJECTION, USP | Fresenius Kabi Canada Ltd | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2022 | RISEDRONATE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 17, 2022 | APO-TAPENTADOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2022 | AURO-QUETIAPINE | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2022 | NUVAXOVID | Novavax Inc. | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 17, 2022 | APO-TAPENTADOL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2022 | ABIRATERONE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Admin |
| February 17, 2022 | APO-TAPENTADOL | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 17, 2022 | ALLEGRA-D | Sanofi Consumer Health Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 17, 2022 | APO-CAPECITABINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2022 | PMS-ABIRATERONE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2022 | FLUNARIZINE | AA Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2022 | SANDOZ MYCOPHENOLATE MOFETIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 17, 2022 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2022 | DIACETYLMORPHINE HYDROCHLORIDE | Pharmascience Inc. | New Drug Submission (NDS) · Other |
| February 16, 2022 | MELOXICAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 16, 2022 | BROMOCRIPTINE | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2022 | PMS-ONDANSETRON ODT | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 16, 2022 | ATOMOXETINE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 16, 2022 | KINOX | Airgas Therapeutics, Llc | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2022 | AMOXICILLIN CAPSULES BP | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2022 | SANDOZ CANDESARTAN PLUS | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 16, 2022 | BROMAZEPAM | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2022 | GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 16, 2022 | PRO-GUANFACINE XR | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| February 16, 2022 | BORTEZOMIB FOR INJECTION | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2022 | MAR-LACOSAMIDE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2022 | APO-MYCOPHENOLATE MOFETIL | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 15, 2022 | TARO-ENALAPRIL | Sun Pharma Canada Inc. | Abbreviated New Drug Submission (ANDS) · Labelling Only |
| February 15, 2022 | LOPRESOR SR | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2022 | COMFORTAN | Eurovet Animal Health B V | Supplement to a New Drug Submission (SNDS) · Other |
| February 15, 2022 | PLAVIX | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2022 | SANDOZ ANASTROZOLE | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2022 | NYVEPRIA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2022 | BIMZELX | Ucb Canada Inc | New Drug Submission (NDS) · New Active Substance (NAS) |
| February 14, 2022 | INTELLI-DESVENLAFAXINE | Intellipharmaceutics Corp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2022 | MELPHALAN FOR INJECTION | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2022 | PMSC-ATORVASTATIN | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2022 | AZILECT | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 14, 2022 | SANDOZ AMBRISENTAN | Sandoz Canada Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2022 | INTELLI-DESVENLAFAXINE | Intellipharmaceutics Corp | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2022 | JAMP DESVENLAFAXINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2022 | DESVENLAFAXINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2022 | TEVA-DESVENLAFAXINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 14, 2022 | JAMP DESVENLAFAXINE | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2022 | DESVENLAFAXINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 14, 2022 | TEVA-DESVENLAFAXINE | Teva Canada Limited | Abbreviated New Drug Submission (ANDS) · Other |
| February 11, 2022 | CEFAZOLIN SODIUM FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2022 | PMS-QUETIAPINE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2022 | IPG-CIPROFLOXACIN | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 11, 2022 | AG-GUANFACINE XR | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 11, 2022 | LISINOPRIL | Sanis Health Inc. | New Drug Submission (NDS) · Admin |
| February 11, 2022 | TRANDOLAPRIL | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 11, 2022 | CIMETIDINE | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2022 | OLESTYR | Pharmascience Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2022 | FERRLECIT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 11, 2022 | SILDENAFIL TABLETS | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2022 | EYLEA | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2022 | CEFAZOLIN FOR INJECTION | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2022 | PMSC-ESCITALOPRAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2022 | ACH-QUETIAPINE FUMARATE XR | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 10, 2022 | CANESTEN 1% TOPICAL CREAM | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2022 | TARO-CALCIPOTRIOL / BETAMETHASONE GEL | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| February 10, 2022 | CANESORAL; CANESORAL COMBI; CANESORAL COMBI 1 DAY | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2022 | CANESTEN 1 DAY INTERNAL CREAM; CANESTEN 3 DAY INTERNAL CREAM; CANESTEN 6 DAY INTERNAL CREAM; CANESTEN COMBI 1 DAY; CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS; CANESTEN COMBI 3 DAY; CANESTEN EXTERNAL ANTIFUNGAL CREAM; CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 10, 2022 | NRA-CELECOXIB | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 10, 2022 | BETAHISTINE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 9, 2022 | GLN-OLMESARTAN | Glenmark Pharmaceuticals Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 9, 2022 | ZOPICLONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 9, 2022 | ESTRACE | Acerus Pharmaceuticals Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| February 9, 2022 | MAR-LETROZOLE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 9, 2022 | APO-LOXAPINE | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 8, 2022 | ZYTIGA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2022 | IMFINZI | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 8, 2022 | TARO-LENALIDOMIDE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2022 | CIPROFLOXACIN TABLETS USP | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 8, 2022 | SOLU-MEDROL | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2022 | APO-TELMISARTAN/HCTZ | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2022 | VELCADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2022 | TEVA-INDOMETHACIN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 7, 2022 | NAT-LENALIDOMIDE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 7, 2022 | AMLODIPINE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2022 | MAR-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 7, 2022 | MAR-ATENOLOL | Marcan Pharmaceuticals Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 7, 2022 | DEXMEDESED | Dechra Veterinary Products Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| February 4, 2022 | FLUMIST QUADRIVALENT | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 4, 2022 | NRA-AZITHROMYCIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 4, 2022 | LEVETIRACETAM | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 4, 2022 | AG-CETIRIZINE | Angita Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 4, 2022 | GIVLAARI | Alnylam Netherlands B.V. | Supplement to a New Drug Submission (SNDS) · Other |
| February 4, 2022 | MICAFUNGIN SODIUM FOR INJECTION | Juno Pharmaceuticals Corp. | Abbreviated New Drug Submission (ANDS) · Other |
| February 4, 2022 | IBUPROFEN; IBUPROFEN CAPLETS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2022 | APO-OXCARBAZEPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 4, 2022 | STALEVO | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2022 | PENTAMIDINE ISETIONATE FOR INJECTION BP | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2022 | OCUFLOX | Allergan Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2022 | IDARUBICIN | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 3, 2022 | TARO-RAMIPRIL HCTZ | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2022 | APO-MIRTAZAPINE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2022 | PMS-ARIPIPRAZOLE | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| February 3, 2022 | TALZENNA | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2022 | RIVA-METOPROLOL-L | Laboratoire Riva Inc. | Supplement to a New Drug Submission (SNDS) · Admin |
| February 2, 2022 | CINACALCET | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| February 2, 2022 | INTELENCE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2022 | FLUAD; FLUAD PEDIATRIC | Seqirus Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2022 | LOKELMA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 2, 2022 | MAR-CLOPIDOGREL | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| February 2, 2022 | ZYVOXAM | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2022 | TEVA-IPRATROPIUM STERINEBS | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2022 | GLUCAGEN; GLUCAGEN HYPOKIT | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| February 1, 2022 | APO-GEFITINIB | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2022 | LANSOPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 31, 2022 | PRO-CLONAZEPAM | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| January 31, 2022 | TEVA-CARBAMAZEPINE | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 31, 2022 | ELMIRON | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 31, 2022 | SANDOZ MYCOPHENOLATE MOFETIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2022 | PMS-EVEROLIMUS | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2022 | PMS-GALANTAMINE ER | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2022 | APO-DUTASTERIDE | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 31, 2022 | AGRYLIN | Takeda Canada Incorporated | Supplement to a New Drug Submission (SNDS) · Other |
| January 29, 2022 | ONE-ALPHA | Cheplapharm Arzneimittel Gmbh | New Drug Submission (NDS) · Labelling Only |
| January 28, 2022 | GLICLAZIDE MR | Sanis Health Inc. | New Drug Submission (NDS) · Labelling Only |
| January 28, 2022 | M-IRBESARTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 28, 2022 | IPG-ANASTROZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2022 | MAR-METHIMAZOLE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2022 | IPG-TOPIRAMATE | Marcan Pharmaceuticals Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 28, 2022 | RINVOQ | AbbVie Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2022 | ARTISS | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2022 | ONTRUZANT | Samsung Bioepis Co., Ltd | New Drug Submission (NDS) · Other |
| January 28, 2022 | LANSOPRAZOLE | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 28, 2022 | PRO-TOPIRAMATE | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 28, 2022 | PARIET | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2022 | PENTOXIFYLLINE SR | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2022 | PROHANCE | Bracco Imaging Canada | Supplement to a New Drug Submission (SNDS) · Other |
| January 28, 2022 | ALDACTAZIDE 25; ALDACTAZIDE 50 | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2022 | INCLUNOX; INCLUNOX HP | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2022 | TEVA-BUPRENORPHINE/NALOXONE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2022 | NRA-ATORVASTATIN | Nora Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 27, 2022 | OLMESARTAN/HCTZ | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 27, 2022 | LOSEC MUPS | Cheplapharm Arzneimittel Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 27, 2022 | EDECRIN | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2022 | VITRAKVI | Bayer Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2022 | TEVA-PROFEN | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2022 | OCTREOTIDE ACETATE OMEGA | Omega Laboratories Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 26, 2022 | FROVA | Endo Pharmaceuticals Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 26, 2022 | MULTIMIN 90 | Warburton Technology Limited | New Drug Submission (NDS) · Other |
| January 25, 2022 | ORGARAN | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2022 | GLUMETZA; GLUMETZA (SB) | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2022 | PRO-CLONAZEPAM | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| January 25, 2022 | APO-OXYBUTYNIN | Apotex Inc. | New Drug Submission (NDS) · Admin |
| January 25, 2022 | M-LEVETIRACETAM | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 25, 2022 | DUTASTERIDE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 25, 2022 | RIVA-IRBESARTAN | Laboratoire Riva Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 25, 2022 | XTANDI | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2022 | PEMETREXED DISODIUM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2022 | TARO-CIPROFLOX | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2022 | ACT QUETIAPINE | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 25, 2022 | RETIN-A | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2022 | FAMPYRA | Biogen Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 25, 2022 | MINT-ACYCLOVIR | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 24, 2022 | CLOPIDOGREL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 24, 2022 | IBUPROFEN LIQUID GELS | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2022 | ILUMYA | Sun Pharmaceutical Industries Limited | New Drug Submission (NDS) · Admin |
| January 24, 2022 | IBUPROFEN CAPLETS 200 MG; IBUPROFEN TABLETS 200 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2022 | APO-TAMOX | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2022 | MYFORTIC | Novartis Pharmaceuticals Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2022 | MEN'S ROGAINE FOAM 5%; WOMEN'S ROGAINE FOAM 5% | Johnson & Johnson Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2022 | DAURISMO | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2022 | 3TC | Viiv Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2022 | VEKLURY | Gilead Sciences Canada Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 24, 2022 | APO-LEVOCARB | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 24, 2022 | DIAZEPAM | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2022 | PMS-CIPROFLOXACIN XL | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2022 | SOHONOS | Ipsen Biopharmaceuticals Canada Inc | New Drug Submission (NDS) · Priority-NAS |
| January 21, 2022 | ACH-MYCOPHENOLATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2022 | REMICADE | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2022 | TAGRISSO | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2022 | DARZALEX SC | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2022 | NAT-AZACITIDINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2022 | LINEZOLID INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 21, 2022 | WELLBUTRIN SR | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 21, 2022 | AZITHROMYCIN FOR INJECTION | Generic Medical Partners Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 20, 2022 | METRONIDAZOLE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 20, 2022 | PMS-DICLOFENAC | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2022 | ANAPROX; ANAPROX DS | Atnahs Pharma Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2022 | RACTOPAMINE 100 | Bio Agri Mix Lp | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2022 | TEVA-AMPHETAMINE XR | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2022 | TARO-AMPHETAMINE XR | Sun Pharma Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2022 | PMS-MELOXICAM | Pharmascience Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2022 | APO-TACROLIMUS | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2022 | M-VALSARTAN | Mantra Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 20, 2022 | APO-FLUOXETINE | Apotex Inc. | New Drug Submission (NDS) · Admin |
| January 20, 2022 | APO-BROMAZEPAM | Apotex Inc. | New Drug Submission (NDS) · Admin |
| January 20, 2022 | TEVA-DICLOFENAC-K | Teva Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 20, 2022 | MICRO +6 CONCENTRATE | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2022 | MICRO PLUS 6 CONCENTRATE; MICRO PLUS 6 PEDIATRIC | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2022 | MICRO +4 REGULAR STRENGTH | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 20, 2022 | MICRO MN | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2022 | RAMIPRIL | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 19, 2022 | LEMTRADA | Sanofi Genzyme, A Division Of Sanofi-Aventis Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2022 | KOVALTRY | Bayer Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2022 | TEVA-DICLOFENAC EC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 19, 2022 | ACH-HYDROXYCHLOROQUINE SULFATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 19, 2022 | APO-MONTELUKAST | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2022 | JAMP LEVETIRACETAM TABLETS | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2022 | JAMP DULOXETINE | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2022 | AG-TELMISARTAN | Angita Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 18, 2022 | PRO-SAXAGLIPTIN | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 18, 2022 | ROSUVASTATIN | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 18, 2022 | ATHENA-ONDANSETRON ODT | Athena Pharmaceutiques Sas | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2022 | ZAVESCA | Janssen Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2022 | LUPIN-PROPRANOLOL LA | Lupin Pharma Canada Limited | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2022 | MINT-AMOXI/CLAV | Mint Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 18, 2022 | MEZERA | Avir Pharma Inc | New Drug Submission (NDS) · Other |
| January 18, 2022 | TRELEGY ELLIPTA | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 18, 2022 | ANAFRANIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2022 | ASA 81 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2022 | VOLTAREN EMULGEL EXTRA STRENGTH; VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH | Glaxosmithkline Consumer Healthcare Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2022 | TEVA-NAPROXEN; TEVA-NAPROXEN EC | Teva Canada Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 17, 2022 | SANDOZ TRANDOLAPRIL | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2022 | ENTERIC COATED DAILY LOW DOSE ASA 81 MG | Vita Health Products Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 17, 2022 | PAXLOVID | Pfizer Canada Ulc | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 14, 2022 | HYQVIA | Takeda Canada Incorporated | New Drug Submission (NDS) · New Active Substance (NAS) |
| January 14, 2022 | OLANZAPINE ODT | Sivem Pharmaceuticals Ulc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 14, 2022 | ACH-METHOTREXATE | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 14, 2022 | BENVYON | Pfizer Canada Ulc | New Drug Submission (NDS) · Other |
| January 14, 2022 | DILTIAZEM CD | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 14, 2022 | NAT-ANASTROZOLE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 14, 2022 | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 14, 2022 | AA-THEO LA | AA Pharma Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 14, 2022 | TECENTRIQ | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Priority |
| January 14, 2022 | JAMP FINGOLIMOD | JAMP Pharma Corporation | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2022 | LETROZOLE | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 13, 2022 | TWINRIX; TWINRIX JUNIOR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2022 | HAVRIX 1440; HAVRIX 720 JUNIOR | Glaxosmithkline Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2022 | DUPIXENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2022 | ITULATEK | Alk-Abello Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2022 | CIPRALEX | Lundbeck Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2022 | RIVA-PERINDOPRIL | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 13, 2022 | EZETIMIBE | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 13, 2022 | VALSARTAN-HCTZ | Pro Doc Limitee | Abbreviated New Drug Submission (ANDS) · Admin |
| January 13, 2022 | ONDANSETRON ODT | Sanis Health Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 13, 2022 | SANDOZ CARBAMAZEPINE CR | Sandoz Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2022 | TARO-CAPECITABINE | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2022 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Auro Pharma Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 13, 2022 | XOFLUZA | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 13, 2022 | POTASSIUM CHLORIDE INJECTION | Baxter Corporation | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2022 | PRALUENT | Sanofi-Aventis Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2022 | SPIKEVAX | Modernatx, Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2022 | CLOPIDOGREL | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2022 | KINERET | Swedish Orphan Biovitrum Ab (Publ) | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2022 | CYSVIEW | Photocure Asa | New Drug Submission (NDS) · Admin |
| January 12, 2022 | CEFTRIAXONE FOR INJECTION | Fresenius Kabi Canada Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 12, 2022 | VERZENIO | Eli Lilly Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 12, 2022 | JAMP-CARVEDILOL | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 11, 2022 | NAPROSYN | Atnahs Pharma Uk Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2022 | ATENOLOL | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| January 11, 2022 | ACH-PREGABALIN | Accord Healthcare Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 11, 2022 | DALACIN C PHOSPHATE | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2022 | DALACIN C FLAVOURED GRANULES | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 11, 2022 | DALACIN C | Pfizer Canada Ulc | Supplement to a New Drug Submission (SNDS) · Other |
| January 10, 2022 | TENOFOVIR | Sivem Pharmaceuticals Ulc | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2022 | CITALOPRAM-10 | Pro Doc Limitee | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 10, 2022 | RIVA-FLUOXETINE | Laboratoire Riva Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 10, 2022 | RISPERIDONE | Sanis Health Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 10, 2022 | CEQUA | Sun Pharmaceutical Industries Limited | New Drug Submission (NDS) · Admin |
| January 10, 2022 | PRO-FUROSEMIDE | Pro Doc Limitee | Supplement to a New Drug Submission (SNDS) · Admin |
| January 10, 2022 | AVENTYL | AA Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Admin |
| January 10, 2022 | REDDY-LENALIDOMIDE | Dr Reddys Laboratories Ltd | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 10, 2022 | MAR-CLONIDINE | Marcan Pharmaceuticals Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 10, 2022 | MINT-ONDANSETRON SOLUTION | Mint Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 10, 2022 | ACARIZAX | Alk-Abello Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 10, 2022 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sterimax Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2022 | ARIXTRA | Aspen Pharmacare Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2022 | NITOMAN | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2022 | LIBRAX | Bausch Health, Canada Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2022 | TARO-CIPROFLOXACIN | Taro Pharmaceuticals Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2022 | LORAZEPAM INJECTION USP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2022 | CEFTRIAXONE SODIUM FOR INJECTION BP | Sandoz Canada Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 7, 2022 | APO-LISINOPRIL | Apotex Inc. | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2022 | OCTASA | Tillotts Pharma Gmbh | Supplement to a New Drug Submission (SNDS) · Other |
| January 7, 2022 | TARO-SUNITINIB | Taro Pharmaceuticals Inc | Abbreviated New Drug Submission (ANDS) · Other |
| January 6, 2022 | JAMP GUANFACINE XR | JAMP Pharma Corporation | Abbreviated New Drug Submission (ANDS) · Other |
| January 6, 2022 | APO-GUANFACINE XR | Apotex Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2022 | NAT-QUETIAPINE | Natco Pharma (Canada) Inc | Supplement to an Abbreviated New Drug Submission (SANDS) · Admin |
| January 5, 2022 | XOSPATA | Astellas Pharma Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2022 | PHESGO | Hoffmann-La Roche Limited | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2022 | APO-LORAZEPAM | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |
| January 5, 2022 | AURO-METHOTREXATE | Auro Pharma Inc. | Abbreviated New Drug Submission (ANDS) · Other |
| January 5, 2022 | SIMLANDI | JAMP Pharma Corporation | New Drug Submission (NDS) · Other |
| January 5, 2022 | POT-PEN | Bio Agri Mix Lp | New Drug Submission (NDS) · Admin |
| January 5, 2022 | POT-PEN | Bio Agri Mix Lp | New Drug Submission (NDS) · Admin |
| January 5, 2022 | BUSPIRONE-10; BUSPIRONE-5 | Pro Doc Limitee | New Drug Submission (NDS) · Admin |
| January 5, 2022 | BRILINTA | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2022 | XERMELO | Ipsen Biopharmaceuticals Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 5, 2022 | SEROQUEL XR | Astrazeneca Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2022 | OZEMPIC | Novo Nordisk Canada Inc | Supplement to a New Drug Submission (SNDS) · Other |
| January 4, 2022 | ODOMZO | Sun Pharmaceutical Industries Limited | New Drug Submission (NDS) · Admin |
| January 4, 2022 | APO-SAXAGLIPTIN | Apotex Inc. | Supplement to an Abbreviated New Drug Submission (SANDS) · Other |